PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"34910859","Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico","Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group.","N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15.","Dunkle LM","N Engl J Med","2022","2021/12/15","PMC8693692","","10.1056/NEJMoa2116185"
"34495421","Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer","Omori S, Harada H, Mori K, Hisamatsu Y, Tsuboguchi Y, Yoshioka H, Morinaga R, Daga H, Kurata T, Takahashi T.","Invest New Drugs. 2022 Feb;40(1):106-114. doi: 10.1007/s10637-021-01155-w. Epub 2021 Sep 8.","Omori S","Invest New Drugs","2022","2021/09/08","","","10.1007/s10637-021-01155-w"
"35127902","Role of carbon nanotracers in lymph node dissection of advanced gastric cancer and the selection of preoperative labeling time","Zhao K, Shan BQ, Gao YP, Xu JY.","World J Clin Cases. 2022 Jan 21;10(3):870-881. doi: 10.12998/wjcc.v10.i3.870.","Zhao K","World J Clin Cases","2022","2022/02/07","PMC8790434","","10.12998/wjcc.v10.i3.870"
"34907220","Application of green synthesized WO(3)-poly glutamic acid nanobiocomposite for early stage biosensing of breast cancer using electrochemical approach","Nasrollahpour H, Naseri A, Rashidi MR, Khalilzadeh B.","Sci Rep. 2021 Dec 14;11(1):23994. doi: 10.1038/s41598-021-03209-8.","Nasrollahpour H","Sci Rep","2021","2021/12/15","PMC8671486","","10.1038/s41598-021-03209-8"
"34923912","The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma","Su D.","Bioengineered. 2021 Dec;12(2):11124-11135. doi: 10.1080/21655979.2021.2001239.","Su D","Bioengineered","2021","2021/12/20","PMC8810100","","10.1080/21655979.2021.2001239"
"34753884","Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer","Yoshimura N, Sawa K, Nakai T, Matsumoto Y, Mitsuoka S, Kimura T, Asai K, Yana T, Kawaguchi T, Hirata K.","Am J Clin Oncol. 2021 Dec 1;44(12):613-618. doi: 10.1097/COC.0000000000000876.","Yoshimura N","Am J Clin Oncol","2021","2021/11/10","","","10.1097/COC.0000000000000876"
"34637337","nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors","Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R, Cranmer L, Gordon EM, Hornick JL, Du H, Grigorian B, Schmid AN, Hou S, Harris K, Kwiatkowski DJ, Desai NP, Dickson MA.","J Clin Oncol. 2021 Nov 20;39(33):3660-3670. doi: 10.1200/JCO.21.01728. Epub 2021 Oct 12.","Wagner AJ","J Clin Oncol","2021","2021/10/12","PMC8601264","","10.1200/JCO.21.01728"
"34523232","Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402","Miyauchi E, Tanaka H, Nakamura A, Harada T, Nakagawa T, Morita M, Jingu D, Kuda T, Gamou S, Saito R, Inoue A.","Thorac Cancer. 2021 Nov;12(21):2886-2893. doi: 10.1111/1759-7714.14149. Epub 2021 Sep 14.","Miyauchi E","Thorac Cancer","2021","2021/09/15","PMC8563146","","10.1111/1759-7714.14149"
"33751208","Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients","Ishikawa T, Kageyama S, Miyahara Y, Okayama T, Kokura S, Wang L, Sato E, Yagita H, Itoh Y, Shiku H.","Cancer Immunol Immunother. 2021 Nov;70(11):3081-3091. doi: 10.1007/s00262-021-02892-w. Epub 2021 Mar 22.","Ishikawa T","Cancer Immunol Immunother","2021","2021/03/22","","","10.1007/s00262-021-02892-w"
"34243976","Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer","Krasner CN, Campos SM, Young CL, Chadda KR, Lee H, Birrer MJ, Horowitz NS, Konstantinopoulos PA, D'Ascanio AM, Matulonis UA, Penson RT.","Gynecol Oncol. 2021 Sep;162(3):661-666. doi: 10.1016/j.ygyno.2021.07.002. Epub 2021 Jul 7.","Krasner CN","Gynecol Oncol","2021","2021/07/10","","","10.1016/j.ygyno.2021.07.002"
"33915251","Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC","Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I.","J Thorac Oncol. 2021 Sep;16(9):1523-1532. doi: 10.1016/j.jtho.2021.03.027. Epub 2021 Apr 27.","Yoneshima Y","J Thorac Oncol","2021","2021/04/29","","","10.1016/j.jtho.2021.03.027"
"34446057","Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)","Yamada D, Kobayashi S, Takahashi H, Akita H, Yamada T, Asaoka T, Shimizu J, Takeda Y, Yokoyama S, Tsujie M, Tomokuni A, Tanemura M, Morimoto O, Murakami M, Kim Y, Nakahira S, Hama N, Sugimoto K, Hashimoto K, Doki Y, Eguchi H.","Trials. 2021 Aug 26;22(1):568. doi: 10.1186/s13063-021-05541-w.","Yamada D","Trials","2021","2021/08/27","PMC8394677","","10.1186/s13063-021-05541-w"
"34219000","Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer","Miles D, Gligorov J, André F, Cameron D, Schneeweiss A, Barrios C, Xu B, Wardley A, Kaen D, Andrade L, Semiglazov V, Reinisch M, Patel S, Patre M, Morales L, Patel SL, Kaul M, Barata T, O'Shaughnessy J; IMpassion131 investigators.","Ann Oncol. 2021 Aug;32(8):994-1004. doi: 10.1016/j.annonc.2021.05.801. Epub 2021 Jul 1.","Miles D","Ann Oncol","2021","2021/07/05","","","10.1016/j.annonc.2021.05.801"
"33594602","First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies","Piha-Paul SA, Thein KZ, De Souza P, Kefford R, Gangadhar T, Smith C, Schuster S, Zamboni WC, Dees CE, Markman B.","Invest New Drugs. 2021 Aug;39(4):1047-1056. doi: 10.1007/s10637-021-01081-x. Epub 2021 Feb 16.","Piha-Paul SA","Invest New Drugs","2021","2021/02/17","","","10.1007/s10637-021-01081-x"
"33961915","Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)","Verry C, Dufort S, Villa J, Gavard M, Iriart C, Grand S, Charles J, Chovelon B, Cracowski JL, Quesada JL, Mendoza C, Sancey L, Lehmann A, Jover F, Giraud JY, Lux F, Crémillieux Y, McMahon S, Pauwels PJ, Cagney D, Berbeco R, Aizer A, Deutsch E, Loeffler M, Le Duc G, Tillement O, Balosso J.","Radiother Oncol. 2021 Jul;160:159-165. doi: 10.1016/j.radonc.2021.04.021. Epub 2021 May 5.","Verry C","Radiother Oncol","2021","2021/05/07","","","10.1016/j.radonc.2021.04.021"
"33634324","A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers","Ma WW, Zhu M, Lam ET, Diamond JR, Dy GK, Fisher GA, Goff LW, Alberts S, Bui LA, Sanghal A, Kothekar M, Khopade A, Chimote G, Faulkner R, Eckhardt SG, Adjei AA, Jimeno A.","Cancer Chemother Pharmacol. 2021 Jun;87(6):779-788. doi: 10.1007/s00280-021-04235-z. Epub 2021 Feb 26.","Ma WW","Cancer Chemother Pharmacol","2021","2021/02/26","","","10.1007/s00280-021-04235-z"
"34050041","Patient specific, imaging-informed modeling of rhenium-186 nanoliposome delivery via convection-enhanced delivery in glioblastoma multiforme","Woodall RT, Hormuth Ii DA, Wu C, Abdelmalik MRA, Phillips WT, Bao A, Hughes TJR, Brenner AJ, Yankeelov TE.","Biomed Phys Eng Express. 2021 May 28;7(4). doi: 10.1088/2057-1976/ac02a6.","Woodall RT","Biomed Phys Eng Express","2021","2021/05/29","","","10.1088/2057-1976/ac02a6"
"33976352","Carbon nanoparticle suspension could help get a more accurate nodal staging for patient with rectal cancer","Ge W, Li Q, Liu WJ, Zhang XQ, Fan XS, Shao LH, Tao L, Guan WX, Chen G.","Sci Rep. 2021 May 11;11(1):9933. doi: 10.1038/s41598-021-89541-5.","Ge W","Sci Rep","2021","2021/05/12","PMC8113261","","10.1038/s41598-021-89541-5"
"33548860","Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial","Adkins D, Ley J, Atiq O, Powell S, Spanos WC, Gitau M, Rigden C, Palka K, Liu J, Oppelt P.","Oral Oncol. 2021 Apr;115:105173. doi: 10.1016/j.oraloncology.2020.105173. Epub 2021 Feb 3.","Adkins D","Oral Oncol","2021","2021/02/06","PMC8579485","NIHMS1688064","10.1016/j.oraloncology.2020.105173"
"32930483","Role of carbon nanoparticle suspension in sentinel lymph node biopsy for early-stage cervical cancer: a prospective study","Ya X, Qian W, Huiqing L, Haixiao W, Weiwei Z, Jing B, Lei C, Jianping Y, Shuping Y, Jiaya M, Dong W, Ruixia G.","BJOG. 2021 Apr;128(5):890-898. doi: 10.1111/1471-0528.16504. Epub 2020 Oct 7.","Ya X","BJOG","2021","2020/09/15","","","10.1111/1471-0528.16504"
"33692132","A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma","Kumthekar P, Ko CH, Paunesku T, Dixit K, Sonabend AM, Bloch O, Tate M, Schwartz M, Zuckerman L, Lezon R, Lukas RV, Jovanovic B, McCortney K, Colman H, Chen S, Lai B, Antipova O, Deng J, Li L, Tommasini-Ghelfi S, Hurley LA, Unruh D, Sharma NV, Kandpal M, Kouri FM, Davuluri RV, Brat DJ, Muzzio M, Glass M, Vijayakumar V, Heidel J, Giles FJ, Adams AK, James CD, Woloschak GE, Horbinski C, Stegh AH.","Sci Transl Med. 2021 Mar 10;13(584):eabb3945. doi: 10.1126/scitranslmed.abb3945.","Kumthekar P","Sci Transl Med","2021","2021/03/11","PMC8272521","NIHMS1708902","10.1126/scitranslmed.abb3945"
"33683482","nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial","Oppelt P, Ley J, Daly M, Rich J, Paniello R, Jackson RS, Pipkorn P, Liu J, Gay H, Palka K, Neupane P, Powell S, Spanos WC, Gitau M, Zevallos J, Thorstad W, Adkins D.","Med Oncol. 2021 Mar 8;38(4):35. doi: 10.1007/s12032-021-01479-w.","Oppelt P","Med Oncol","2021","2021/03/08","","","10.1007/s12032-021-01479-w"
"33734415","Use of Ultrasmall Core-Shell Fluorescent Silica Nanoparticles for Image-Guided Sentinel Lymph Node Biopsy in Head and Neck Melanoma: A Nonrandomized Clinical Trial","Zanoni DK, Stambuk HE, Madajewski B, Montero PH, Matsuura D, Busam KJ, Ma K, Turker MZ, Sequeira S, Gonen M, Zanzonico P, Wiesner U, Bradbury MS, Patel SG.","JAMA Netw Open. 2021 Mar 1;4(3):e211936. doi: 10.1001/jamanetworkopen.2021.1936.","Zanoni DK","JAMA Netw Open","2021","2021/03/18","PMC7974643","","10.1001/jamanetworkopen.2021.1936"
"33607477","Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx","Hoffmann C, Calugaru V, Borcoman E, Moreno V, Calvo E, Liem X, Salas S, Doger B, Jouffroy T, Mirabel X, Rodriguez J, Chilles A, Bernois K, Dimitriu M, Fakhry N, Hee Kam SW, Le Tourneau C.","Eur J Cancer. 2021 Mar;146:135-144. doi: 10.1016/j.ejca.2021.01.007. Epub 2021 Feb 16.","Hoffmann C","Eur J Cancer","2021","2021/02/19","","","10.1016/j.ejca.2021.01.007"
"33390325","A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer","Duska LR, Krasner CN, O'Malley DM, Hays JL, Modesitt SC, Mathews CA, Moore KN, Thaker PH, Miller A, Purdy C, Zamboni WC, Lucas AT, Supko JG, Schilder RJ.","Gynecol Oncol. 2021 Mar;160(3):688-695. doi: 10.1016/j.ygyno.2020.12.025. Epub 2020 Dec 31.","Duska LR","Gynecol Oncol","2021","2021/01/04","","","10.1016/j.ygyno.2020.12.025"
"33136231","Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial","Fujitani K, Shitara K, Takashima A, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Hosaka H, Komatsu Y, Shimada K, Kawabata R, Ohdan H, Kodera Y, Nakamura M, Nakajima TE, Miyata Y, Moriwaki T, Kusumoto T, Nishikawa K, Ogata K, Shimura M, Morita S, Koizumi W.","Gastric Cancer. 2021 Mar;24(2):467-476. doi: 10.1007/s10120-020-01131-y. Epub 2020 Nov 2.","Fujitani K","Gastric Cancer","2021","2020/11/02","PMC7902565","","10.1007/s10120-020-01131-y"
"33378609","Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group.","N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.","Baden LR","N Engl J Med","2021","2020/12/30","PMC7787219","","10.1056/NEJMoa2035389"
"33341707","Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer","Tsurutani J, Hara F, Kitada M, Takahashi M, Kikawa Y, Kato H, Sakata E, Naito Y, Hasegawa Y, Saito T, Iwasa T, Taira N, Takashima T, Kashiwabara K, Aihara T, Mukai H.","Breast. 2021 Feb;55:63-68. doi: 10.1016/j.breast.2020.12.002. Epub 2020 Dec 9.","Tsurutani J","Breast","2021","2020/12/20","PMC7753189","","10.1016/j.breast.2020.12.002"
"32459889","Population Pharmacokinetics and Exposure-Response Analysis of nab-Paclitaxel in Pediatric Patients With Recurrent or Refractory Solid Tumors","Li Y, Kassir N, Chen N, Wang X, Palmisano M, Zhou S.","Clin Pharmacol Drug Dev. 2021 Feb;10(2):115-130. doi: 10.1002/cpdd.803. Epub 2020 May 27.","Li Y","Clin Pharmacol Drug Dev","2021","2020/05/28","","","10.1002/cpdd.803"
"33477309","Tin, Titanium, Tantalum, Vanadium and Niobium Oxide Based Sensors to Detect Colorectal Cancer Exhalations in Blood Samples","Astolfi M, Rispoli G, Anania G, Artioli E, Nevoso V, Zonta G, Malagù C.","Molecules. 2021 Jan 17;26(2):466. doi: 10.3390/molecules26020466.","Astolfi M","Molecules","2021","2021/01/22","PMC7829789","","10.3390/molecules26020466"
"33431819","ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro","Boyacıoğlu Ö, Bilgiç E, Varan C, Bilensoy E, Nemutlu E, Sevim D, Kocaefe Ç, Korkusuz P.","Cell Death Dis. 2021 Jan 11;12(1):56. doi: 10.1038/s41419-020-03274-3.","Boyacıoğlu Ö","Cell Death Dis","2021","2021/01/12","PMC7801394","","10.1038/s41419-020-03274-3"
"33158764","A Phase I/II Study of Biweekly Carboplatin and Nab-paclitaxel With Concurrent Radiotherapy for Patients With Locally Advanced Unresectable Stage III Non-small-cell Lung Cancer","Tanaka H, Hasegawa Y, Makiguchi T, Okumura F, Tabe C, Shiratori T, Ishioka Y, Itoga M, Taima K, Yokouchi J, Hatayama Y, Aoki M, Tasaka S.","Clin Lung Cancer. 2021 Jan;22(1):42-48. doi: 10.1016/j.cllc.2020.09.016. Epub 2020 Oct 14.","Tanaka H","Clin Lung Cancer","2021","2020/11/07","","","10.1016/j.cllc.2020.09.016"
"33130217","Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial","Shi M, Gu A, Tu H, Huang C, Wang H, Yu Z, Wang X, Cao L, Shu Y, Wang H, Yang R, Li X, Chang J, Hu Y, Shen P, Hu Y, Guo Z, Tao M, Zhang Y, Liu X, Sun Q, Zhang X, Jiang Z, Zhao J, Chen F, Yu H, Zhang W, Sun J, Li D, Zhou J, Han B, Wu YL.","Ann Oncol. 2021 Jan;32(1):85-96. doi: 10.1016/j.annonc.2020.10.479. Epub 2020 Oct 29.","Shi M","Ann Oncol","2021","2020/11/01","","","10.1016/j.annonc.2020.10.479"
"33097414","Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial","Spigel DR, Jotte RM, Aix SP, Gressot L, Morgensztern D, McCleod M, Socinski MA, Daniel D, Juan-Vidal O, Mileham KF, West H, Page R, Reinmuth N, Knoble J, Chen T, Bhore R, Wolfsteiner M, Ong TJ, Gridelli C, Thomas M; ABOUND.sqm Investigators.","Clin Lung Cancer. 2021 Jan;22(1):6-15.e4. doi: 10.1016/j.cllc.2020.09.007. Epub 2020 Sep 18.","Spigel DR","Clin Lung Cancer","2021","2020/10/24","","","10.1016/j.cllc.2020.09.007"
"32877909","Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study)","Nakamura M, Ojima T, Katsuda M, Hayata K, Kitadani J, Nakamori M, Yamaue H.","Oncology. 2021;99(1):57-61. doi: 10.1159/000509396. Epub 2020 Sep 2.","Nakamura M","Oncology","2021","2020/09/03","","","10.1159/000509396"
"32926227","A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302)","Tamura S, Taniguchi H, Nishikawa K, Imamura H, Fujita J, Takeno A, Matsuyama J, Kimura Y, Kawada J, Hirao M, Hirota M, Fujitani K, Kurokawa Y, Sakai D, Kawakami H, Shimokawa T, Satoh T.","Int J Clin Oncol. 2020 Dec;25(12):2035-2043. doi: 10.1007/s10147-020-01768-w. Epub 2020 Sep 14.","Tamura S","Int J Clin Oncol","2020","2020/09/14","PMC7677284","","10.1007/s10147-020-01768-w"
"32631710","A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study","Rubio IT, Rodriguez-Revuelto R, Espinosa-Bravo M, Siso C, Rivero J, Esgueva A.","Eur J Surg Oncol. 2020 Dec;46(12):2195-2201. doi: 10.1016/j.ejso.2020.06.018. Epub 2020 Jun 18.","Rubio IT","Eur J Surg Oncol","2020","2020/07/08","","","10.1016/j.ejso.2020.06.018"
"32897402","Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors","Schmidt KT, Huitema ADR, Dorlo TPC, Peer CJ, Cordes LM, Sciuto L, Wroblewski S, Pommier Y, Madan RA, Thomas A, Figg WD.","Cancer Chemother Pharmacol. 2020 Oct;86(4):475-486. doi: 10.1007/s00280-020-04134-9. Epub 2020 Sep 8.","Schmidt KT","Cancer Chemother Pharmacol","2020","2020/09/08","PMC7515962","","10.1007/s00280-020-04134-9"
"33433509","Effectiveness of curcumin mouthwash on radiation-induced oral mucositis among head and neck cancer patients: A triple-blind, pilot randomised controlled trial","Shah S, Rath H, Sharma G, Senapati SN, Mishra E.","Indian J Dent Res. 2020 Sep-Oct;31(5):718-727. doi: 10.4103/ijdr.IJDR_822_18.","Shah S","Indian J Dent Res","2020","2021/01/12","","","10.4103/ijdr.IJDR_822_18"
"32381487","A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma","Chawla SP, Goel S, Chow W, Braiteh F, Singh AS, Olson JEG, Osada A, Bobe I, Riedel RF.","Clin Cancer Res. 2020 Aug 15;26(16):4225-4232. doi: 10.1158/1078-0432.CCR-20-0591. Epub 2020 May 7.","Chawla SP","Clin Cancer Res","2020","2020/05/09","","","10.1158/1078-0432.CCR-20-0591"
"32574006","A Randomized Comparison of Carbon Nanoparticles in Endoscopic Lymph Node Dissection Via the Bilateral Areola Approach for Papillary Thyroid Cancer","Zhang D, Fu Y, Dionigi G, Hu Y, Zhang J, Wang T, Xue G, Sun H.","Surg Laparosc Endosc Percutan Tech. 2020 Aug;30(4):291-299. doi: 10.1097/SLE.0000000000000793.","Zhang D","Surg Laparosc Endosc Percutan Tech","2020","2020/06/24","","","10.1097/SLE.0000000000000793"
"32501121","Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients","Fabi A, Ferretti G, Malaguti P, Gasparro S, Nisticò C, Arpino G, Papaldo P, Russillo M, Catania G, Schettini F, Giannarelli D, Cognetti F.","Future Oncol. 2020 Aug;16(22):1629-1637. doi: 10.2217/fon-2019-0742. Epub 2020 Jun 5.","Fabi A","Future Oncol","2020","2020/06/06","","","10.2217/fon-2019-0742"
"32357963","MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial","Sarker D, Plummer R, Meyer T, Sodergren MH, Basu B, Chee CE, Huang KW, Palmer DH, Ma YT, Evans TRJ, Spalding DRC, Pai M, Sharma R, Pinato DJ, Spicer J, Hunter S, Kwatra V, Nicholls JP, Collin D, Nutbrown R, Glenny H, Fairbairn S, Reebye V, Voutila J, Dorman S, Andrikakou P, Lloyd P, Felstead S, Vasara J, Habib R, Wood C, Saetrom P, Huber HE, Blakey DC, Rossi JJ, Habib N.","Clin Cancer Res. 2020 Aug 1;26(15):3936-3946. doi: 10.1158/1078-0432.CCR-20-0414. Epub 2020 May 1.","Sarker D","Clin Cancer Res","2020","2020/05/03","","","10.1158/1078-0432.CCR-20-0414"
"32731530","Small Extracellular Vesicles Isolated from Serum May Serve as Signal-Enhancers for the Monitoring of CNS Tumors","Dobra G, Bukva M, Szabo Z, Bruszel B, Harmati M, Gyukity-Sebestyen E, Jenei A, Szucs M, Horvath P, Biro T, Klekner A, Buzas K.","Int J Mol Sci. 2020 Jul 28;21(15):5359. doi: 10.3390/ijms21155359.","Dobra G","Int J Mol Sci","2020","2020/08/01","PMC7432723","","10.3390/ijms21155359"
"32321718","Intratumoral Comparison of Nanoparticle Entrapped Docetaxel (CPC634) with Conventional Docetaxel in Patients with Solid Tumors","Atrafi F, van Eerden RAG, van Hylckama Vlieg MAM, Oomen-de Hoop E, de Bruijn P, Lolkema MP, Moelker A, Rijcken CJ, Hanssen R, Sparreboom A, Eskens FALM, Mathijssen RHJ, Koolen SLW.","Clin Cancer Res. 2020 Jul 15;26(14):3537-3545. doi: 10.1158/1078-0432.CCR-20-0008. Epub 2020 Apr 22.","Atrafi F","Clin Cancer Res","2020","2020/04/24","","","10.1158/1078-0432.CCR-20-0008"
"32591522","Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery","Voskuil FJ, Steinkamp PJ, Zhao T, van der Vegt B, Koller M, Doff JJ, Jayalakshmi Y, Hartung JP, Gao J, Sumer BD, Witjes MJH, van Dam GM; SHINE study group.","Nat Commun. 2020 Jun 26;11(1):3257. doi: 10.1038/s41467-020-16814-4.","Voskuil FJ","Nat Commun","2020","2020/06/28","PMC7320194","","10.1038/s41467-020-16814-4"
"32460834","Moving a neodymium magnet promotes the migration of a magnetic tracer and increases the monitoring counts on the skin surface of sentinel lymph nodes in breast cancer","Makita M, Manabe E, Kurita T, Takei H, Nakamura S, Kuwahata A, Sekino M, Kusakabe M, Ohashi Y.","BMC Med Imaging. 2020 May 27;20(1):58. doi: 10.1186/s12880-020-00459-2.","Makita M","BMC Med Imaging","2020","2020/05/29","PMC7254765","","10.1186/s12880-020-00459-2"
"32489332","Hybrid (2D/3D) Dosimetry of Radiolabeled Gold Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer","Ramírez-Nava G, Santos-Cuevas C, Ferro-Flores G, Ocampo-García B, Chairez I, Gómez-Argumosa E, Abundiz-López L, García-Pérez FO.","Contrast Media Mol Imaging. 2020 May 6;2020:2728134. doi: 10.1155/2020/2728134. eCollection 2020.","Ramírez-Nava G","Contrast Media Mol Imaging","2020","2020/06/04","PMC7229544","","10.1155/2020/2728134"
"32083298","The safety and effectiveness of carbon nanoparticles suspension in tracking lymph node metastases of colorectal cancer: a prospective randomized controlled trial","Wang R, Mo S, Liu Q, Zhang W, Zhang Z, He Y, Cai G, Li X.","Jpn J Clin Oncol. 2020 May 5;50(5):535-542. doi: 10.1093/jjco/hyaa011.","Wang R","Jpn J Clin Oncol","2020","2020/02/22","","","10.1093/jjco/hyaa011"
"32238921","Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, Brenner AJ, Park K, Lee JL, Kim TY, Shin S, Becerra CR, Falchook G, Stoudemire J, Martin D, Kelnar K, Peltier H, Bonato V, Bader AG, Smith S, Kim S, O'Neill V, Beg MS.","Br J Cancer. 2020 May;122(11):1630-1637. doi: 10.1038/s41416-020-0802-1. Epub 2020 Apr 2.","Hong DS","Br J Cancer","2020","2020/04/03","PMC7251107","","10.1038/s41416-020-0802-1"
"32045316","Application of Nanocarbon in Breast Approach Endoscopic Thyroidectomy Thyroid Cancer Surgery","Ma JJ, Zhang DB, Zhang WF, Wang X.","J Laparoendosc Adv Surg Tech A. 2020 May;30(5):547-552. doi: 10.1089/lap.2019.0794. Epub 2020 Feb 11.","Ma JJ","J Laparoendosc Adv Surg Tech A","2020","2020/02/12","","","10.1089/lap.2019.0794"
"32350847","Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy","Sandoughdaran S, Razzaghdoust A, Tabibi A, Basiri A, Simforoosh N, Mofid B.","Urol J. 2020 Apr 30;18(3):295-300. doi: 10.22037/uj.v0i0.5719.","Sandoughdaran S","Urol J","2020","2020/05/01","","","10.22037/uj.v0i0.5719"
"31927166","Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma","Schmidt KT, Peer CJ, Huitema ADR, Williams MD, Wroblewski S, Schellens JHM, Madan RA, Figg WD.","J Pharm Biomed Anal. 2020 Mar 20;181:113073. doi: 10.1016/j.jpba.2019.113073. Epub 2019 Dec 27.","Schmidt KT","J Pharm Biomed Anal","2020","2020/01/14","PMC7068816","NIHMS1549312","10.1016/j.jpba.2019.113073"
"31831564","Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma","Azmi AS, Khan HY, Muqbil I, Aboukameel A, Neggers JE, Daelemans D, Mahipal A, Dyson G, Kamgar M, Al-Hallak MN, Tesfaye A, Kim S, Shidham V, M Mohammad R, Philip PA.","Clin Cancer Res. 2020 Mar 15;26(6):1338-1348. doi: 10.1158/1078-0432.CCR-19-1728. Epub 2019 Dec 12.","Azmi AS","Clin Cancer Res","2020","2019/12/14","PMC7073299","NIHMS1546538","10.1158/1078-0432.CCR-19-1728"
"31943168","Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy","Weiss JM, Pennell N, Deal AM, Morgensztern D, Bradford DS, Crane J, West HJ, Lee C, Pecot C, Stevenson JP, Irvin W, Socinski M, Stinchcombe T, Villaruz LC, Muss HB.","Cancer. 2020 Mar 1;126(5):1060-1067. doi: 10.1002/cncr.32573. Epub 2020 Jan 14.","Weiss JM","Cancer","2020","2020/01/17","","","10.1002/cncr.32573"
"31932899","Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics","Kontopoulou E, Strachan S, Reinhardt K, Kunz F, Walter C, Walkenfort B, Jastrow H, Hasenberg M, Giebel B, von Neuhoff N, Reinhardt D, Thakur BK.","Ann Hematol. 2020 Mar;99(3):459-475. doi: 10.1007/s00277-019-03866-w. Epub 2020 Jan 13.","Kontopoulou E","Ann Hematol","2020","2020/01/15","","","10.1007/s00277-019-03866-w"
"32206111","Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI","Muehe AM, Siedek F, Theruvath AJ, Seekins J, Spunt SL, Pribnow A, Hazard FK, Liang T, Daldrup-Link H.","Theranostics. 2020 Feb 18;10(8):3612-3621. doi: 10.7150/thno.40606. eCollection 2020.","Muehe AM","Theranostics","2020","2020/03/25","PMC7069081","","10.7150/thno.40606"
"32045475","Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL","Awasthi R, Pacaud L, Waldron E, Tam CS, Jäger U, Borchmann P, Jaglowski S, Foley SR, van Besien K, Wagner-Johnston ND, Kersten MJ, Schuster SJ, Salles G, Maziarz RT, Anak Ö, Del Corral C, Chu J, Gershgorin I, Pruteanu-Malinici I, Chakraborty A, Mueller KT, Waller EK.","Blood Adv. 2020 Feb 11;4(3):560-572. doi: 10.1182/bloodadvances.2019000525.","Awasthi R","Blood Adv","2020","2020/02/12","PMC7013261","","10.1182/bloodadvances.2019000525"
"32086925","[Clinical application of carbon nanoparticles suspension in operation of papillary thyroid carcinoma]","Wang C, Wang X, Liu L.","Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Feb;34(2):165-169. doi: 10.13201/j.issn.1001-1781.2020.02.016.","Wang C","Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi","2020","2020/02/23","","","10.13201/j.issn.1001-1781.2020.02.016"
"31901783","Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial","Kanbayashi Y, Sakaguchi K, Ishikawa T, Ouchi Y, Nakatsukasa K, Tabuchi Y, Kanehisa F, Hiramatsu M, Takagi R, Yokota I, Katoh N, Taguchi T.","Breast. 2020 Feb;49:219-224. doi: 10.1016/j.breast.2019.12.011. Epub 2019 Dec 20.","Kanbayashi Y","Breast","2020","2020/01/06","PMC7375545","","10.1016/j.breast.2019.12.011"
"31597485","The Role of Dispensing Device and Label Warnings on Dosing for Sunscreen Application: A Randomized Trial","Harben A, Robinson S, de la Fuente J, Bix L.","Health Educ Behav. 2020 Feb;47(1):143-152. doi: 10.1177/1090198119879739. Epub 2019 Oct 9.","Harben A","Health Educ Behav","2020","2019/10/11","","","10.1177/1090198119879739"
"31958932","[Application of endoscopic tattooing with carbon nanoparticlet in the treatment for advanced colorectal cancer]","Wang R, Zhan HL, Li DZ, Li HT, Yu L, Wang W.","Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jan 25;23(1):56-64. doi: 10.3760/cma.j.issn.1671-0274.2020.01.010.","Wang R","Zhonghua Wei Chang Wai Ke Za Zhi","2020","2020/01/22","","","10.3760/cma.j.issn.1671-0274.2020.01.010"
"32021173","New Approaches in Breast Cancer Therapy Through Green Nanotechnology and Nano-Ayurvedic Medicine - Pre-Clinical and Pilot Human Clinical Investigations","Khoobchandani M, Katti KK, Karikachery AR, Thipe VC, Srisrimal D, Dhurvas Mohandoss DK, Darshakumar RD, Joshi CM, Katti KV.","Int J Nanomedicine. 2020 Jan 13;15:181-197. doi: 10.2147/IJN.S219042. eCollection 2020.","Khoobchandani M","Int J Nanomedicine","2020","2020/02/06","PMC6970107","","10.2147/IJN.S219042"
"32674095","Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer","Kotake M, Kuwako T, Imai H, Tomizawa Y, Kaira K, Yoshii A, Ochiai M, Miura Y, Osaki T, Sakurai R, Takei K, Minato K, Saito R.","Chemotherapy. 2020;65(1-2):21-28. doi: 10.1159/000508715. Epub 2020 Jul 16.","Kotake M","Chemotherapy","2020","2020/07/17","","","10.1159/000508715"
"31859604","[Clinical protocol for the topical use of a cream with nanoparticles and vitamin E to prevent radiodermatitis in patients with breast cancer]]","Schmidt FMQ, González CVS, Mattar RC, Lopes LB, Santos MFD, de Gouveia Santos VLC.","J Wound Care. 2020 Jan 1;29(LatAm sup 1):18-26. doi: 10.12968/jowc.2020.29.LatAm_sup_1.18.","Schmidt FMQ","J Wound Care","2020","2019/12/21","","","10.12968/jowc.2020.29.LatAm_sup_1.18"
"31810960","Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients","Ota D, Akatsuka S, Nishi T, Kato T, Takeuchi M, Tsuji M, Fukuuchi A.","Anticancer Res. 2019 Dec;39(12):6903-6907. doi: 10.21873/anticanres.13910.","Ota D","Anticancer Res","2019","2019/12/08","","","10.21873/anticanres.13910"
"31667855","Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe","Taruno K, Kurita T, Kuwahata A, Yanagihara K, Enokido K, Katayose Y, Nakamura S, Takei H, Sekino M, Kusakabe M.","J Surg Oncol. 2019 Dec;120(8):1391-1396. doi: 10.1002/jso.25747. Epub 2019 Oct 30.","Taruno K","J Surg Oncol","2019","2019/11/01","","","10.1002/jso.25747"
"31570235","Testing the Feasibility of SentiMag/Sienna+ for Detecting Inguinal Sentinel Nodes in Penile Cancer (SentiPen): An eUROGEN and National Cancer Research Institute Trial","Cleaveland P, Lau M, Parnham A, Murby B, Ashworth D, Manohoran P, Taylor B, Bell J, Najran P, Oliveira P, Shanks J, Sangar V.","Eur Urol. 2019 Dec;76(6):874-875. doi: 10.1016/j.eururo.2019.09.007. Epub 2019 Sep 27.","Cleaveland P","Eur Urol","2019","2019/10/02","","","10.1016/j.eururo.2019.09.007"
"31309381","A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer","Hasegawa R, Okuwaki K, Kida M, Yamauchi H, Kawaguchi Y, Matsumoto T, Kaneko T, Miyata E, Uehara K, Iwai T, Watanabe M, Kurosu T, Imaizumi H, Ohno T, Koizumi W.","Int J Clin Oncol. 2019 Dec;24(12):1574-1581. doi: 10.1007/s10147-019-01511-0. Epub 2019 Jul 15.","Hasegawa R","Int J Clin Oncol","2019","2019/07/17","","","10.1007/s10147-019-01511-0"
"31220446","Safety and efficacy of a metal stent covered with a silicone membrane containing integrated silver particles in preventing biofilm and sludge formation in endoscopic drainage of malignant biliary obstruction: a phase 2 pilot study","Lee TH, Jung MK, Kim TK, Pack CG, Park YK, Kim SO, Park DH.","Gastrointest Endosc. 2019 Oct;90(4):663-672.e2. doi: 10.1016/j.gie.2019.06.007. Epub 2019 Jun 18.","Lee TH","Gastrointest Endosc","2019","2019/06/21","","","10.1016/j.gie.2019.06.007"
"31490376","Clinical feasibility of imaging with indocyanine green combined with carbon nanoparticles for sentinel lymph node identification in papillary thyroid microcarcinoma","Zhang X, Shen YP, Li JG, Chen G.","Medicine (Baltimore). 2019 Sep;98(36):e16935. doi: 10.1097/MD.0000000000016935.","Zhang X","Medicine (Baltimore)","2019","2019/09/07","PMC6738994","","10.1097/MD.0000000000016935"
"31082269","NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto","Untch M, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Schem C, Wiebringhaus H, Kümmel S, Warm M, Fasching PA, Just M, Hanusch C, Hackmann J, Blohmer JU, Rhiem K, Schmitt WD, Furlanetto J, Gerber B, Huober J, Nekljudova V, von Minckwitz G, Loibl S.","J Clin Oncol. 2019 Sep 1;37(25):2226-2234. doi: 10.1200/JCO.18.01842. Epub 2019 May 13.","Untch M","J Clin Oncol","2019","2019/05/15","","","10.1200/JCO.18.01842"
"30445188","Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification","Zuo J, Wu LY, Cheng M, Bai P, Lei CZ, Li N, Zhang GY, Zhao D, Li B.","J Minim Invasive Gynecol. 2019 Sep-Oct;26(6):1125-1132. doi: 10.1016/j.jmig.2018.11.002. Epub 2018 Nov 14.","Zuo J","J Minim Invasive Gynecol","2019","2018/11/17","","","10.1016/j.jmig.2018.11.002"
"31296491","NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial","Bonvalot S, Rutkowski PL, Thariat J, Carrère S, Ducassou A, Sunyach MP, Agoston P, Hong A, Mervoyer A, Rastrelli M, Moreno V, Li RK, Tiangco B, Herraez AC, Gronchi A, Mangel L, Sy-Ortin T, Hohenberger P, de Baère T, Le Cesne A, Helfre S, Saada-Bouzid E, Borkowska A, Anghel R, Co A, Gebhart M, Kantor G, Montero A, Loong HH, Vergés R, Lapeire L, Dema S, Kacso G, Austen L, Moureau-Zabotto L, Servois V, Wardelmann E, Terrier P, Lazar AJ, Bovée JVMG, Le Péchoux C, Papai Z.","Lancet Oncol. 2019 Aug;20(8):1148-1159. doi: 10.1016/S1470-2045(19)30326-2. Epub 2019 Jul 8.","Bonvalot S","Lancet Oncol","2019","2019/07/13","","","10.1016/S1470-2045(19)30326-2"
"30993397","A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer","Kato Y, Okuma Y, Watanabe K, Yomota M, Kawai S, Hosomi Y, Okamura T.","Cancer Chemother Pharmacol. 2019 Aug;84(2):351-358. doi: 10.1007/s00280-019-03843-0. Epub 2019 Apr 16.","Kato Y","Cancer Chemother Pharmacol","2019","2019/04/18","PMC6647220","","10.1007/s00280-019-03843-0"
"30938103","A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement","Harada D, Kozuki T, Nogami N, Bessho A, Hosokawa S, Fukamatsu N, Hotta K, Ohashi K, Kubo T, Yoshioka H, Yokoyama T, Sone N, Kuyama S, Kudo K, Yasugi M, Takigawa N, Oze I, Kiura K.","Asia Pac J Clin Oncol. 2019 Aug;15(4):250-256. doi: 10.1111/ajco.13147. Epub 2019 Apr 1.","Harada D","Asia Pac J Clin Oncol","2019","2019/04/03","PMC6849786","","10.1111/ajco.13147"
"30998813","Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial","Shroff RT, Javle MM, Xiao L, Kaseb AO, Varadhachary GR, Wolff RA, Raghav KPS, Iwasaki M, Masci P, Ramanathan RK, Ahn DH, Bekaii-Saab TS, Borad MJ.","JAMA Oncol. 2019 Jun 1;5(6):824-830. doi: 10.1001/jamaoncol.2019.0270.","Shroff RT","JAMA Oncol","2019","2019/04/19","PMC6567834","","10.1001/jamaoncol.2019.0270"
"30963212","De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer","Tanaka S, Matsunami N, Morishima H, Oda N, Takashima T, Noda S, Kashiwagi S, Tauchi Y, Asano Y, Kimura K, Fujioka H, Terasawa R, Kawaguchi K, Ikari A, Morimoto T, Michishita S, Kobayashi T, Sakane J, Nitta T, Sato N, Hokimoto N, Nishida Y, Iwamoto M.","Cancer Chemother Pharmacol. 2019 Jun;83(6):1099-1104. doi: 10.1007/s00280-019-03836-z. Epub 2019 Apr 8.","Tanaka S","Cancer Chemother Pharmacol","2019","2019/04/10","","","10.1007/s00280-019-03836-z"
"30954567","Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial","Merle P, Blanc JF, Phelip JM, Pelletier G, Bronowicki JP, Touchefeu Y, Pageaux G, Gerolami R, Habersetzer F, Nguyen-Khac E, Casadei-Gardini A, Borbath I, Tran A, Wege H, Saad AS, Colombo M, Abergel A, Richou C, Waked I, Yee NS, Molé A, Attali P, Le Boulicaut J, Vasseur B; RELIVE Investigators.","Lancet Gastroenterol Hepatol. 2019 Jun;4(6):454-465. doi: 10.1016/S2468-1253(19)30040-8. Epub 2019 Apr 4.","Merle P","Lancet Gastroenterol Hepatol","2019","2019/04/08","","","10.1016/S2468-1253(19)30040-8"
"30858085","Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer","Sanoff HK, Moon DH, Moore DT, Boles J, Bui C, Blackstock W, O'Neil BH, Subramaniam S, McRee AJ, Carlson C, Lee MS, Tepper JE, Wang AZ.","Nanomedicine. 2019 Jun;18:189-195. doi: 10.1016/j.nano.2019.02.021. Epub 2019 Mar 8.","Sanoff HK","Nanomedicine","2019","2019/03/13","PMC7881832","NIHMS1660645","10.1016/j.nano.2019.02.021"
"30790149","Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma","Akiyama N, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inami N, Matsuura S, Kaida Y, Uto T, Matsui T, Asada K, Matsuda H, Fujii M, Toyoshima M, Suda T.","Invest New Drugs. 2019 Jun;37(3):531-537. doi: 10.1007/s10637-019-00747-x. Epub 2019 Feb 21.","Akiyama N","Invest New Drugs","2019","2019/02/22","","","10.1007/s10637-019-00747-x"
"30598500","An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma","El Dika I, Lim HY, Yong WP, Lin CC, Yoon JH, Modiano M, Freilich B, Choi HJ, Chao TY, Kelley RK, Brown J, Knox J, Ryoo BY, Yau T, Abou-Alfa GK.","Oncologist. 2019 Jun;24(6):747-e218. doi: 10.1634/theoncologist.2018-0838. Epub 2018 Dec 31.","El Dika I","Oncologist","2019","2019/01/02","PMC6656521","","10.1634/theoncologist.2018-0838"
"30221566","Progesterone-loaded nanosized transethosomes for vaginal permeation enhancement: formulation, statistical optimization, and clinical evaluation in anovulatory polycystic ovary syndrome","Salem HF, Kharshoum RM, Abou-Taleb HA, AbouTaleb HA, AbouElhassan KM.","J Liposome Res. 2019 Jun;29(2):183-194. doi: 10.1080/08982104.2018.1524483. Epub 2018 Nov 13.","Salem HF","J Liposome Res","2019","2018/09/18","","","10.1080/08982104.2018.1524483"
"30839104","Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study)","Karakatsanis A, Hersi AF, Pistiolis L, Olofsson Bagge R, Lykoudis PM, Eriksson S, Wärnberg F; SentiNot Trialists Group.","Br J Surg. 2019 May;106(6):720-728. doi: 10.1002/bjs.11110. Epub 2019 Mar 6.","Karakatsanis A","Br J Surg","2019","2019/03/07","","","10.1002/bjs.11110"
"30952749","Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II Trial","Tokunaga S, Takashima T, Kashiwagi S, Noda S, Kawajiri H, Tokumoto M, Nishimura S, Nishimori T, Ikeda K, Ogawa Y, Mizuyama Y, Sunami T, Tezuka K, Yamagata S, Ishikawa T, Kudoh S, Takada M, Hirakawa K, Ohira M.","Anticancer Res. 2019 Apr;39(4):2053-2059. doi: 10.21873/anticanres.13316.","Tokunaga S","Anticancer Res","2019","2019/04/07","","","10.21873/anticanres.13316"
"30580490","Effect of activated carbon nanoparticles on lymph node harvest in patients with colorectal cancer","Tang L, Sun L, Zhao P, Kong D.","Colorectal Dis. 2019 Apr;21(4):427-431. doi: 10.1111/codi.14538. Epub 2019 Jan 12.","Tang L","Colorectal Dis","2019","2018/12/24","","","10.1111/codi.14538"
"30745582","A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients","Fujiwara Y, Mukai H, Saeki T, Ro J, Lin YC, Nagai SE, Lee KS, Watanabe J, Ohtani S, Kim SB, Kuroi K, Tsugawa K, Tokuda Y, Iwata H, Park YH, Yang Y, Nambu Y.","Br J Cancer. 2019 Mar;120(5):475-480. doi: 10.1038/s41416-019-0391-z. Epub 2019 Feb 12.","Fujiwara Y","Br J Cancer","2019","2019/02/13","PMC6461876","","10.1038/s41416-019-0391-z"
"30763338","Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response","Murphy C, Muscat A, Ashley D, Mukaro V, West L, Liao Y, Chisanga D, Shi W, Collins I, Baron-Hay S, Patil S, Lindeman G, Khasraw M.","PLoS One. 2019 Feb 14;14(2):e0210891. doi: 10.1371/journal.pone.0210891. eCollection 2019.","Murphy C","PLoS One","2019","2019/02/15","PMC6375556","","10.1371/journal.pone.0210891"
"30523758","Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2","Macarulla T, Pazo-Cid R, Guillén-Ponce C, López R, Vera R, Reboredo M, Muñoz Martin A, Rivera F, Díaz Beveridge R, La Casta A, Martín Valadés J, Martínez-Galán J, Ales I, Sastre J, Perea S, Hidalgo M.","J Clin Oncol. 2019 Jan 20;37(3):230-238. doi: 10.1200/JCO.18.00089. Epub 2018 Dec 4.","Macarulla T","J Clin Oncol","2019","2018/12/08","","","10.1200/JCO.18.00089"
"30529902","Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)","Watson S, de la Fouchardière C, Kim S, Cohen R, Bachet JB, Tournigand C, Ferraz JM, Lefevre M, Colin D, Svrcek M, Meurisse A, Louvet C.","Eur J Cancer. 2019 Jan;107:46-52. doi: 10.1016/j.ejca.2018.11.006. Epub 2018 Dec 7.","Watson S","Eur J Cancer","2019","2018/12/12","","","10.1016/j.ejca.2018.11.006"
"29855738","Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial","Takashima A, Shitara K, Fujitani K, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Fujii H, Muro K, Esaki T, Choda Y, Takano T, Chin K, Sato A, Goto M, Fukushima N, Hara T, Machida N, Ohta M, Boku N, Shimura M, Morita S, Koizumi W.","Gastric Cancer. 2019 Jan;22(1):155-163. doi: 10.1007/s10120-018-0838-6. Epub 2018 May 31.","Takashima A","Gastric Cancer","2019","2018/06/02","PMC6315007","","10.1007/s10120-018-0838-6"
"30383906","ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC)","Morgensztern D, Cobo M, Ponce Aix S, Postmus PE, Lewanski CR, Bennouna J, Fischer JR, Juan-Vidal O, Stewart DJ, Fasola G, Ardizzoni A, Bhore R, Wolfsteiner M, Talbot DC, Jin Ong T, Govindan R, On Behalf Of The Abound L Investigators.","Cancer. 2018 Dec 15;124(24):4667-4675. doi: 10.1002/cncr.31779. Epub 2018 Nov 1.","Morgensztern D","Cancer","2018","2018/11/02","","","10.1002/cncr.31779"
"30504409","A Phase II Study of Tri-weekly Low-dose Nab-paclitaxel Chemotherapy for Patients with Advanced Gastric Cancer","Sato S, Kunisaki C, Tanaka Y, Sato K, Miyamoto H, Yukawa N, Fujii Y, Kimura J, Takagawa R, Takahashi M, Kosaka T, Akiyama H, Saigusa Y, Taguri M, Yamanaka T, Endo I.","Anticancer Res. 2018 Dec;38(12):6911-6917. doi: 10.21873/anticanres.13068.","Sato S","Anticancer Res","2018","2018/12/04","","","10.21873/anticanres.13068"
"30178032","Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial","Sahai V, Catalano PJ, Zalupski MM, Lubner SJ, Menge MR, Nimeiri HS, Munshi HG, Benson AB 3rd, O'Dwyer PJ.","JAMA Oncol. 2018 Dec 1;4(12):1707-1712. doi: 10.1001/jamaoncol.2018.3277.","Sahai V","JAMA Oncol","2018","2018/09/05","PMC6440720","","10.1001/jamaoncol.2018.3277"
"30072191","Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2(-) Early-stage Breast Cancer","Kuwayama T, Nakamura S, Hayashi N, Takano T, Tsugawa K, Sato T, Kitani A, Okuyama H, Yamauchi H.","Clin Breast Cancer. 2018 Dec;18(6):474-480. doi: 10.1016/j.clbc.2018.06.012. Epub 2018 Jun 27.","Kuwayama T","Clin Breast Cancer","2018","2018/08/04","","","10.1016/j.clbc.2018.06.012"
"30345906","Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer","Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Hegg R, Im SA, Shaw Wright G, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA; IMpassion130 Trial Investigators.","N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20.","Schmid P","N Engl J Med","2018","2018/10/23","","","10.1056/NEJMoa1809615"
"30280635","Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer","Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gümüş M, Mazières J, Hermes B, Çay Şenler F, Csőszi T, Fülöp A, Rodríguez-Cid J, Wilson J, Sugawara S, Kato T, Lee KH, Cheng Y, Novello S, Halmos B, Li X, Lubiniecki GM, Piperdi B, Kowalski DM; KEYNOTE-407 Investigators.","N Engl J Med. 2018 Nov 22;379(21):2040-2051. doi: 10.1056/NEJMoa1810865. Epub 2018 Sep 25.","Paz-Ares L","N Engl J Med","2018","2018/10/04","","","10.1056/NEJMoa1810865"
"30347090","Effect of Protocolized Weaning With Early Extubation to Noninvasive Ventilation vs Invasive Weaning on Time to Liberation From Mechanical Ventilation Among Patients With Respiratory Failure: The Breathe Randomized Clinical Trial","Perkins GD, Mistry D, Gates S, Gao F, Snelson C, Hart N, Camporota L, Varley J, Carle C, Paramasivam E, Hoddell B, McAuley DF, Walsh TS, Blackwood B, Rose L, Lamb SE, Petrou S, Young D, Lall R; Breathe Collaborators.","JAMA. 2018 Nov 13;320(18):1881-1888. doi: 10.1001/jama.2018.13763.","Perkins GD","JAMA","2018","2018/10/23","PMC6248131","","10.1001/jama.2018.13763"
"30281875","Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel in untreated patients with metastatic gastric cancer","He MM, Wang F, Jin Y, Yuan SQ, Ren C, Luo HY, Wang ZQ, Qiu MZ, Wang ZX, Zeng ZL, Li YH, Wang FH, Zhang DS, Xu RH.","Cancer Sci. 2018 Nov;109(11):3575-3582. doi: 10.1111/cas.13813. Epub 2018 Oct 26.","He MM","Cancer Sci","2018","2018/10/04","PMC6215885","","10.1111/cas.13813"
"30348118","Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial","Zhao Y, Lv F, Chen S, Wang Z, Zhang J, Zhang S, Cao J, Wang L, Cao E, Wang B, Hu X.","BMC Cancer. 2018 Oct 22;18(1):1019. doi: 10.1186/s12885-018-4936-y.","Zhao Y","BMC Cancer","2018","2018/10/24","PMC6196471","","10.1186/s12885-018-4936-y"
"29978216","Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial","Autio KA, Dreicer R, Anderson J, Garcia JA, Alva A, Hart LL, Milowsky MI, Posadas EM, Ryan CJ, Graf RP, Dittamore R, Schreiber NA, Summa JM, Youssoufian H, Morris MJ, Scher HI.","JAMA Oncol. 2018 Oct 1;4(10):1344-1351. doi: 10.1001/jamaoncol.2018.2168.","Autio KA","JAMA Oncol","2018","2018/07/07","PMC6233779","","10.1001/jamaoncol.2018.2168"
"29452759","Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m(2)) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer","Kojima Y, Kawamoto H, Nishikawa T, Hayami R, Shimo A, Haku E, Akiyama K, Tsugawa K.","Clin Breast Cancer. 2018 Oct;18(5):374-379. doi: 10.1016/j.clbc.2018.01.002. Epub 2018 Jan 11.","Kojima Y","Clin Breast Cancer","2018","2018/02/18","","","10.1016/j.clbc.2018.01.002"
"29960096","Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial Tumors","Young JS, Bernal G, Polster SP, Nunez L, Larsen GF, Mansour N, Podell M, Yamini B.","World Neurosurg. 2018 Sep;117:e698-e704. doi: 10.1016/j.wneu.2018.06.114. Epub 2018 Jun 27.","Young JS","World Neurosurg","2018","2018/07/01","PMC6113082","NIHMS978223","10.1016/j.wneu.2018.06.114"
"29979421","Preoperative injection of carbon nanoparticles is beneficial to the patients with thyroid papillary carcinoma: From a prospective study of 102 cases","Yan S, Zhao W, Wang B, Zhang L.","Medicine (Baltimore). 2018 Jul;97(27):e11364. doi: 10.1097/MD.0000000000011364.","Yan S","Medicine (Baltimore)","2018","2018/07/07","PMC6076069","","10.1097/MD.0000000000011364"
"29945562","Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience","Glassman DC, Palmaira RL, Covington CM, Desai AM, Ku GY, Li J, Harding JJ, Varghese AM, O'Reilly EM, Yu KH.","BMC Cancer. 2018 Jun 27;18(1):693. doi: 10.1186/s12885-018-4605-1.","Glassman DC","BMC Cancer","2018","2018/06/28","PMC6020418","","10.1186/s12885-018-4605-1"
"29132268","Simplifying Logistics and Avoiding the Unnecessary in Patients With Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles","Karakatsanis A, Olofsson H, Stålberg P, Bergkvist L, Abdsaleh S, Wärnberg F.","Scand J Surg. 2018 Jun;107(2):130-137. doi: 10.1177/1457496917738867. Epub 2017 Nov 13.","Karakatsanis A","Scand J Surg","2018","2017/11/15","","","10.1177/1457496917738867"
"28868573","Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies","Shi M, Sun J, Zhou J, Yu H, Yu S, Xia G, Wang L, Teng Y, Liu G, Yu C, Feng J, Shen Y.","Invest New Drugs. 2018 Apr;36(2):269-277. doi: 10.1007/s10637-017-0506-4. Epub 2017 Sep 4.","Shi M","Invest New Drugs","2018","2017/09/05","","","10.1007/s10637-017-0506-4"
"29353164","A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer","Bando H, Shimodaira H, Fujitani K, Takashima A, Yamaguchi K, Nakayama N, Takahashi T, Oki E, Azuma M, Nishina T, Hironaka S, Komatsu Y, Shitara K.","Eur J Cancer. 2018 Mar;91:86-91. doi: 10.1016/j.ejca.2017.11.032. Epub 2018 Jan 30.","Bando H","Eur J Cancer","2018","2018/01/22","","","10.1016/j.ejca.2017.11.032"
"29336900","Combined use of a nanocarbon suspension and (99m)Tc-MIBI for the intra-operative localization of the parathyroid glands","Chen J, Zhou Q, Feng J, Wang J.","Am J Otolaryngol. 2018 Mar-Apr;39(2):138-141. doi: 10.1016/j.amjoto.2017.12.008. Epub 2017 Dec 13.","Chen J","Am J Otolaryngol","2018","2018/01/17","","","10.1016/j.amjoto.2017.12.008"
"29327055","Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial","Gianni L, Mansutti M, Anton A, Calvo L, Bisagni G, Bermejo B, Semiglazov V, Thill M, Chacon JI, Chan A, Morales S, Alvarez I, Plazaola A, Zambetti M, Redfern AD, Dittrich C, Dent RA, Magazzù D, De Fato R, Valagussa P, Tusquets I.","JAMA Oncol. 2018 Mar 1;4(3):302-308. doi: 10.1001/jamaoncol.2017.4612.","Gianni L","JAMA Oncol","2018","2018/01/13","PMC5885830","","10.1001/jamaoncol.2017.4612"
"28597723","Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study","Goyal S, Oak E, Luo J, Cashen AF, Carson K, Fehniger T, DiPersio J, Bartlett NL, Wagner-Johnston ND.","Leuk Lymphoma. 2018 Feb;59(2):357-362. doi: 10.1080/10428194.2017.1330954. Epub 2017 Jun 9.","Goyal S","Leuk Lymphoma","2018","2017/06/10","","","10.1080/10428194.2017.1330954"
"29552762","Assessment of lymph node metastasis in elderly patients with colorectal cancer by sentinel lymph node identification using carbon nanoparticles","Sun J, Zhang J.","J BUON. 2018 Jan-Feb;23(1):68-72.","Sun J","J BUON","2018","2018/03/20","","",""
"29030354","Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors","Subbiah V, Grilley-Olson JE, Combest AJ, Sharma N, Tran RH, Bobe I, Osada A, Takahashi K, Balkissoon J, Camp A, Masada A, Reitsma DJ, Bazhenova LA.","Clin Cancer Res. 2018 Jan 1;24(1):43-51. doi: 10.1158/1078-0432.CCR-17-1114. Epub 2017 Oct 13.","Subbiah V","Clin Cancer Res","2018","2017/10/15","","","10.1158/1078-0432.CCR-17-1114"
"28687482","Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis","Otsubo K, Kishimoto J, Kenmotsu H, Minegishi Y, Ichihara E, Shiraki A, Kato T, Atagi S, Horinouchi H, Ando M, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakanishi Y, Okamoto I.","Clin Lung Cancer. 2018 Jan;19(1):e5-e9. doi: 10.1016/j.cllc.2017.06.003. Epub 2017 Jun 20.","Otsubo K","Clin Lung Cancer","2018","2017/07/09","","","10.1016/j.cllc.2017.06.003"
"29390506","Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer","Anzai M, Morikawa M, Okuno T, Umeda Y, Demura Y, Sonoda T, Yamaguchi M, Kanno K, Shiozaki K, Ameshima S, Akai M, Ishizuka T.","Medicine (Baltimore). 2017 Dec;96(51):e9320. doi: 10.1097/MD.0000000000009320.","Anzai M","Medicine (Baltimore)","2017","2018/02/03","PMC5758208","","10.1097/MD.0000000000009320"
"29078364","Clinical validation of a nanodiamond-embedded thermoplastic biomaterial","Lee DK, Kee T, Liang Z, Hsiou D, Miya D, Wu B, Osawa E, Chow EK, Sung EC, Kang MK, Ho D.","Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9445-E9454. doi: 10.1073/pnas.1711924114. Epub 2017 Oct 23.","Lee DK","Proc Natl Acad Sci U S A","2017","2017/10/29","PMC5692571","","10.1073/pnas.1711924114"
"28950297","A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma","Voss MH, Hussain A, Vogelzang N, Lee JL, Keam B, Rha SY, Vaishampayan U, Harris WB, Richey S, Randall JM, Shaffer D, Cohn A, Crowell T, Li J, Senderowicz A, Stone E, Figlin R, Motzer RJ, Haas NB, Hutson T.","Ann Oncol. 2017 Nov 1;28(11):2754-2760. doi: 10.1093/annonc/mdx493.","Voss MH","Ann Oncol","2017","2017/09/27","","","10.1093/annonc/mdx493"
"28701571","Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis","Martín M, Chacón JI, Antón A, Plazaola A, García-Martínez E, Seguí MA, Sánchez-Rovira P, Palacios J, Calvo L, Esteban C, Espinosa E, Barnadas A, Batista N, Guerrero A, Muñoz M, Romio E, Rodríguez-Martín C, Caballero R, Casas MI, Rojo F, Carrasco E, Antolín S.","Oncologist. 2017 Nov;22(11):1301-1308. doi: 10.1634/theoncologist.2017-0052. Epub 2017 Jul 12.","Martín M","Oncologist","2017","2017/07/14","PMC5679821","","10.1634/theoncologist.2017-0052"
"28579139","A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer","Werner TL, Ray A, Lamb JG, VanBrocklin M, Hueftle K, Cohen AL, Beck AC, Buys SS, Dyess DL, Butler TW, Dumlao TL, Neumayer L, Khong HT.","Clin Breast Cancer. 2017 Nov;17(7):503-509. doi: 10.1016/j.clbc.2017.04.010. Epub 2017 Apr 29.","Werner TL","Clin Breast Cancer","2017","2017/06/06","","","10.1016/j.clbc.2017.04.010"
"28439763","A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer","Yamamoto S, Maeda N, Nagashima Y, Kubo H, Sato Y, Matsui H, Inoue Y, Shindo Y, Kanekiyo S, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yoshino S, Hazama S, Oka M, Nagano H.","Breast Cancer. 2017 Nov;24(6):783-789. doi: 10.1007/s12282-017-0779-7. Epub 2017 Apr 24.","Yamamoto S","Breast Cancer","2017","2017/04/26","","","10.1007/s12282-017-0779-7"
"28756613","Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma","Graziani SR, Vital CG, Morikawa AT, Van Eyll BM, Fernandes Junior HJ, Kalil Filho R, Maranhão RC.","Med Oncol. 2017 Sep;34(9):151. doi: 10.1007/s12032-017-1009-z. Epub 2017 Jul 29.","Graziani SR","Med Oncol","2017","2017/07/31","","","10.1007/s12032-017-1009-z"
"28688052","Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study","Shiroyama T, Tamiya M, Minami S, Takata S, Masuhiro K, Futami-Nishijima Y, Uenami T, Mori M, Koba T, Matsuki T, Takimoto T, Suzuki H, Okamoto N, Komuta K, Hirashima T, Kumanogoh A, Kijima T.","Cancer Chemother Pharmacol. 2017 Sep;80(3):461-467. doi: 10.1007/s00280-017-3385-7. Epub 2017 Jul 7.","Shiroyama T","Cancer Chemother Pharmacol","2017","2017/07/09","","","10.1007/s00280-017-3385-7"
"26783035","The application of carbon nanoparticles in the lymph node biopsy of cN0 papillary thyroid carcinoma: A randomized controlled clinical trial","Xu XF, Gu J.","Asian J Surg. 2017 Sep;40(5):345-349. doi: 10.1016/j.asjsur.2015.11.004. Epub 2016 Jan 15.","Xu XF","Asian J Surg","2017","2016/01/20","","","10.1016/j.asjsur.2015.11.004"
"28298546","(64)Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer","Lee H, Shields AF, Siegel BA, Miller KD, Krop I, Ma CX, LoRusso PM, Munster PN, Campbell K, Gaddy DF, Leonard SC, Geretti E, Blocker SJ, Kirpotin DB, Moyo V, Wickham TJ, Hendriks BS.","Clin Cancer Res. 2017 Aug 1;23(15):4190-4202. doi: 10.1158/1078-0432.CCR-16-3193. Epub 2017 Mar 15.","Lee H","Clin Cancer Res","2017","2017/03/17","PMC6790129","NIHMS1540409","10.1158/1078-0432.CCR-16-3193"
"28622892","A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma","Ke LR, Xia WX, Qiu WZ, Huang XJ, Yu YH, Liang H, Liu GY, Xiang YQ, Guo X, Lv X.","Oral Oncol. 2017 Jul;70:7-13. doi: 10.1016/j.oraloncology.2017.04.018. Epub 2017 May 9.","Ke LR","Oral Oncol","2017","2017/06/18","","","10.1016/j.oraloncology.2017.04.018"
"28050738","Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial","Futamura M, Nagao Y, Ishihara K, Takeuchi M, Nakada T, Kawaguchi Y, Asano M, Kumazawa I, Shiroko T, Morimitsu K, Mori R, Nawa M, Shimokawa T, Yoshida K.","Breast Cancer. 2017 Jul;24(4):615-623. doi: 10.1007/s12282-016-0748-6. Epub 2017 Jan 3.","Futamura M","Breast Cancer","2017","2017/01/05","PMC5487880","","10.1007/s12282-016-0748-6"
"26365441","The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment","Ghilli M, Carretta E, Di Filippo F, Battaglia C, Fustaino L, Galanou I, Di Filippo S, Rucci P, Fantini MP, Roncella M.","Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12385. Epub 2015 Sep 14.","Ghilli M","Eur J Cancer Care (Engl)","2017","2015/09/15","","","10.1111/ecc.12385"
"28643315","[Technical advantages of nano carbon development combined with artery approach in lymph node sorting of rectal cancer]","Zhao Y, Han G, Li J, Gu Y, Ma P, Liu C, Huo M, Zhang J, Cao Y, Zhang S.","Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jun 25;20(6):680-683.","Zhao Y","Zhonghua Wei Chang Wai Ke Za Zhi","2017","2017/06/24","","",""
"28526722","Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301","Miyauchi E, Inoue A, Usui K, Sugawara S, Maemondo M, Saito H, Fujita Y, Kato T, Suzuki T, Harada T, Watanabe H, Nakagawa T, Ichinose M.","Oncologist. 2017 Jun;22(6):640-e59. doi: 10.1634/theoncologist.2017-0059. Epub 2017 May 19.","Miyauchi E","Oncologist","2017","2017/05/21","PMC5469596","","10.1634/theoncologist.2017-0059"
"28054329","A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors","Mukai H, Kogawa T, Matsubara N, Naito Y, Sasaki M, Hosono A.","Invest New Drugs. 2017 Jun;35(3):307-314. doi: 10.1007/s10637-016-0422-z. Epub 2017 Jan 4.","Mukai H","Invest New Drugs","2017","2017/01/06","","","10.1007/s10637-016-0422-z"
"28350787","Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis","Pelzer U, Blanc JF, Melisi D, Cubillo A, Von Hoff DD, Wang-Gillam A, Chen LT, Siveke JT, Wan Y, Solem CT, Botteman MF, Yang Y, de Jong FA, Hubner RA.","Br J Cancer. 2017 May 9;116(10):1247-1253. doi: 10.1038/bjc.2017.67. Epub 2017 Mar 28.","Pelzer U","Br J Cancer","2017","2017/03/29","PMC5482729","","10.1038/bjc.2017.67"
"28256066","Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer","Tamura K, Inoue K, Masuda N, Takao S, Kashiwaba M, Tokuda Y, Iwata H, Yamamoto N, Aogi K, Saeki T, Nakayama T, Sato N, Toyama T, Ishida T, Arioka H, Saito M, Ohno S, Yamauchi H, Yamada K, Watanabe J, Ishiguro H, Fujiwara Y.","Cancer Sci. 2017 May;108(5):987-994. doi: 10.1111/cas.13221. Epub 2017 May 5.","Tamura K","Cancer Sci","2017","2017/03/04","PMC5448660","","10.1111/cas.13221"
"28163086","Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non-muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy","Robins DJ, Sui W, Matulay JT, Ghandour R, Anderson CB, DeCastro GJ, McKiernan JM.","Urology. 2017 May;103:149-153. doi: 10.1016/j.urology.2017.01.018. Epub 2017 Feb 2.","Robins DJ","Urology","2017","2017/02/07","","","10.1016/j.urology.2017.01.018"
"28388900","Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma","Tan Y, Yan B, Xue L, Li Y, Luo X, Ji P.","Lipids Health Dis. 2017 Apr 7;16(1):73. doi: 10.1186/s12944-017-0465-y.","Tan Y","Lipids Health Dis","2017","2017/04/09","PMC5384146","","10.1186/s12944-017-0465-y"
"28404157","Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial","Shitara K, Takashima A, Fujitani K, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Makari Y, Amagai K, Ueda S, Yoshida K, Shimodaira H, Nishina T, Tsuda M, Kurokawa Y, Tamura T, Sasaki Y, Morita S, Koizumi W.","Lancet Gastroenterol Hepatol. 2017 Apr;2(4):277-287. doi: 10.1016/S2468-1253(16)30219-9. Epub 2017 Jan 19.","Shitara K","Lancet Gastroenterol Hepatol","2017","2017/04/14","","","10.1016/S2468-1253(16)30219-9"
"27917453","Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","Beg MS, Brenner AJ, Sachdev J, Borad M, Kang YK, Stoudemire J, Smith S, Bader AG, Kim S, Hong DS.","Invest New Drugs. 2017 Apr;35(2):180-188. doi: 10.1007/s10637-016-0407-y. Epub 2016 Dec 5.","Beg MS","Invest New Drugs","2017","2016/12/06","PMC5893501","NIHMS955503","10.1007/s10637-016-0407-y"
"27998887","First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas","Bonvalot S, Le Pechoux C, De Baere T, Kantor G, Buy X, Stoeckle E, Terrier P, Sargos P, Coindre JM, Lassau N, Ait Sarkouh R, Dimitriu M, Borghi E, Levy L, Deutsch E, Soria JC.","Clin Cancer Res. 2017 Feb 15;23(4):908-917. doi: 10.1158/1078-0432.CCR-16-1297. Epub 2016 Oct 6.","Bonvalot S","Clin Cancer Res","2017","2016/12/22","","","10.1158/1078-0432.CCR-16-1297"
"27696395","A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma","Li Y, Zeng J, Huang M, An J, Bai P, Wu L, Zhang R.","Cancer. 2017 Feb 1;123(3):420-425. doi: 10.1002/cncr.30328. Epub 2016 Oct 3.","Li Y","Cancer","2017","2016/10/04","","","10.1002/cncr.30328"
"27634477","A Carbon Nanoparticle Lymphatic Tracer Protected Parathyroid Glands During Radical Thyroidectomy for Papillary Thyroid Non-Microcarcinoma","Long M, Luo D, Diao F, Huang M, Huang K, Peng X, Lin S, Li H.","Surg Innov. 2017 Feb;24(1):29-34. doi: 10.1177/1553350616668088. Epub 2016 Sep 23.","Long M","Surg Innov","2017","2016/09/17","","","10.1177/1553350616668088"
"28341108","Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer","Yoneshima Y, Morita S, Ando M, Miura S, Yoshioka H, Abe T, Kato T, Kondo M, Hosomi Y, Hotta K, Yamamoto N, Kishimoto J, Nakanishi Y, Okamoto I.","Clin Lung Cancer. 2017 Jan;18(1):100-103. doi: 10.1016/j.cllc.2016.08.003. Epub 2016 Oct 3.","Yoneshima Y","Clin Lung Cancer","2017","2017/03/26","","","10.1016/j.cllc.2016.08.003"
"27995307","Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer","Kaira K, Tomizawa Y, Imai H, Sakurai R, Matsuura M, Yoshii A, Ochiai M, Kotake M, Ebara T, Saitoh JI, Sunaga N, Minato K, Saito R, Hisada T.","Cancer Chemother Pharmacol. 2017 Jan;79(1):165-171. doi: 10.1007/s00280-016-3217-1. Epub 2016 Dec 19.","Kaira K","Cancer Chemother Pharmacol","2017","2016/12/21","","","10.1007/s00280-016-3217-1"
"27919976","Phase I Study of Triweekly Nab-Paclitaxel Combined with S-1 in Patients with HER2-negative Metastatic Breast Cancer","Sakaguchi K, Nakatsukasa K, Taguchi T.","Anticancer Res. 2016 Dec;36(12):6515-6519. doi: 10.21873/anticanres.11252.","Sakaguchi K","Anticancer Res","2016","2016/12/07","","","10.21873/anticanres.11252"
"27764799","Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model","Song SY, Kim KP, Jeong SY, Park J, Park J, Jung J, Chung HK, Lee SW, Seo MH, Lee JS, Jung KH, Choi EK.","Oncotarget. 2016 Nov 22;7(47):77348-77357. doi: 10.18632/oncotarget.12668.","Song SY","Oncotarget","2016","2016/10/21","PMC5363590","","10.18632/oncotarget.12668"
"27871319","A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors","Chiang NJ, Chao TY, Hsieh RK, Wang CH, Wang YW, Yeh CG, Chen LT.","BMC Cancer. 2016 Nov 21;16(1):907. doi: 10.1186/s12885-016-2933-6.","Chiang NJ","BMC Cancer","2016","2016/11/23","PMC5117585","","10.1186/s12885-016-2933-6"
"27620884","Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group","Tsuyuki S, Senda N, Kanng Y, Yamaguchi A, Yoshibayashi H, Kikawa Y, Katakami N, Kato H, Hashimoto T, Okuno T, Yamauchi A, Inamoto T.","Breast Cancer Res Treat. 2016 Nov;160(1):61-67. doi: 10.1007/s10549-016-3977-7. Epub 2016 Sep 12.","Tsuyuki S","Breast Cancer Res Treat","2016","2016/09/14","","","10.1007/s10549-016-3977-7"
"27759629","Potential role of carbon nanoparticles in protection of parathyroid glands in patients with papillary thyroid cancer","Yu W, Zhu L, Xu G, Song Y, Li G, Zhang N.","Medicine (Baltimore). 2016 Oct;95(42):e5002. doi: 10.1097/MD.0000000000005002.","Yu W","Medicine (Baltimore)","2016","2016/10/21","PMC5079313","","10.1097/MD.0000000000005002"
"27580113","Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors","Cai S, Zhang T, Forrest WC, Yang Q, Groer C, Mohr E, Aires DJ, Axiak-Bechtel SM, Flesner BK, Henry CJ, Selting KA, Tate D, Swarz JA, Bryan JN, Forrest ML.","Am J Vet Res. 2016 Sep;77(9):1005-16. doi: 10.2460/ajvr.77.9.1005.","Cai S","Am J Vet Res","2016","2016/09/01","PMC5008241","NIHMS748091","10.2460/ajvr.77.9.1005"
"27357628","Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study","Pirollo KF, Nemunaitis J, Leung PK, Nunan R, Adams J, Chang EH.","Mol Ther. 2016 Sep;24(9):1697-706. doi: 10.1038/mt.2016.135. Epub 2016 Jun 30.","Pirollo KF","Mol Ther","2016","2016/07/01","PMC5113104","","10.1038/mt.2016.135"
"27241116","Potential role for carbon nanoparticles to guide central neck dissection in patients with papillary thyroid cancer","Yu W, Cao X, Xu G, Song Y, Li G, Zheng H, Zhang N.","Surgery. 2016 Sep;160(3):755-61. doi: 10.1016/j.surg.2016.04.017. Epub 2016 May 27.","Yu W","Surgery","2016","2016/06/01","","","10.1016/j.surg.2016.04.017"
"27244882","Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma","Fan Y, Jiang Y, Zhou X, Chen Q, Huang Z, Xu Y, Gong L, Yu H, Yang H, Liu J, Lei T, Zhao Q, Mao W.","Oncotarget. 2016 Aug 2;7(31):50624-50634. doi: 10.18632/oncotarget.9562.","Fan Y","Oncotarget","2016","2016/06/01","PMC5226608","","10.18632/oncotarget.9562"
"27626473","Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles","Shiozaki AA, Senra T, Morikawa AT, Deus DF, Paladino-Filho AT, Pinto IM, Maranhão RC.","Clinics (Sao Paulo). 2016 Aug;71(8):435-9. doi: 10.6061/clinics/2016(08)05.","Shiozaki AA","Clinics (Sao Paulo)","2016","2016/09/15","PMC4975788","","10.6061/clinics/2016(08)05"
"27457310","Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial","Keefe SM, Hoffman-Censits J, Cohen RB, Mamtani R, Heitjan D, Eliasof S, Nixon A, Turnbull B, Garmey EG, Gunnarsson O, Waliki M, Ciconte J, Jayaraman L, Senderowicz A, Tellez AB, Hennessy M, Piscitelli A, Vaughn D, Smith A, Haas NB.","Ann Oncol. 2016 Aug;27(8):1579-85. doi: 10.1093/annonc/mdw188. Epub 2016 Jun 8.","Keefe SM","Ann Oncol","2016","2016/07/27","PMC4959924","","10.1093/annonc/mdw188"
"27339149","A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer","Okuma Y, Hosomi Y, Takahashi S, Nakahara Y, Watanabe K, Nagamata M, Takagi Y, Mikura S.","Cancer Chemother Pharmacol. 2016 Aug;78(2):383-8. doi: 10.1007/s00280-016-3092-9. Epub 2016 Jun 23.","Okuma Y","Cancer Chemother Pharmacol","2016","2016/06/25","","","10.1007/s00280-016-3092-9"
"27316438","A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer","Yoshitomi S, Taira N, Doihara H, Mizoo T, Nogami T, Iwamoto T, Motoki T, Shien T, Ogasawara Y, Matsuoka J, Tsuji H, Mitsuhashi T.","Cancer Chemother Pharmacol. 2016 Aug;78(2):289-94. doi: 10.1007/s00280-016-3091-x. Epub 2016 Jun 17.","Yoshitomi S","Cancer Chemother Pharmacol","2016","2016/06/19","","","10.1007/s00280-016-3091-x"
"26783268","Identifying Parathyroid Glands With Carbon Nanoparticle Suspension Does Not Help Protect Parathyroid Function in Thyroid Surgery: A Prospective, Randomized Control Clinical Study","Liu X, Chang S, Jiang X, Huang P, Yuan Z.","Surg Innov. 2016 Aug;23(4):381-9. doi: 10.1177/1553350615624787. Epub 2016 Jan 17.","Liu X","Surg Innov","2016","2016/01/20","","","10.1177/1553350615624787"
"27411683","Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma","Huang Y, Liang W, Yang Y, Zhao L, Zhao H, Wu X, Zhao Y, Zhang Y, Zhang L.","BMC Cancer. 2016 Jul 13;16:464. doi: 10.1186/s12885-016-2517-5.","Huang Y","BMC Cancer","2016","2016/07/15","PMC4944269","","10.1186/s12885-016-2517-5"
"26847057","Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors","Von Hoff DD, Mita MM, Ramanathan RK, Weiss GJ, Mita AC, LoRusso PM, Burris HA 3rd, Hart LL, Low SC, Parsons DM, Zale SE, Summa JM, Youssoufian H, Sachdev JC.","Clin Cancer Res. 2016 Jul 1;22(13):3157-63. doi: 10.1158/1078-0432.CCR-15-2548. Epub 2016 Feb 4.","Von Hoff DD","Clin Cancer Res","2016","2016/02/06","","","10.1158/1078-0432.CCR-15-2548"
"27117158","The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies","Karakatsanis A, Christiansen PM, Fischer L, Hedin C, Pistioli L, Sund M, Rasmussen NR, Jørnsgård H, Tegnelius D, Eriksson S, Daskalakis K, Wärnberg F, Markopoulos CJ, Bergkvist L.","Breast Cancer Res Treat. 2016 Jun;157(2):281-294. doi: 10.1007/s10549-016-3809-9. Epub 2016 Apr 27.","Karakatsanis A","Breast Cancer Res Treat","2016","2016/04/28","PMC4875068","","10.1007/s10549-016-3809-9"
"26913928","Repetitive Application of Sunscreen Containing Titanium Dioxide Nanoparticles on Human Skin","Coelho SG, Patri AK, Wokovich AM, McNeil SE, Howard PC, Miller SA.","JAMA Dermatol. 2016 Apr;152(4):470-2. doi: 10.1001/jamadermatol.2015.5944.","Coelho SG","JAMA Dermatol","2016","2016/02/26","","","10.1001/jamadermatol.2015.5944"
"26754343","Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial","Houpeau JL, Chauvet MP, Guillemin F, Bendavid-Athias C, Charitansky H, Kramar A, Giard S.","J Surg Oncol. 2016 Apr;113(5):501-7. doi: 10.1002/jso.24164. Epub 2016 Jan 12.","Houpeau JL","J Surg Oncol","2016","2016/01/13","","","10.1002/jso.24164"
"26746803","Evaluation of intraoperative fluorescence imaging-guided surgery in cancer-bearing dogs: a prospective proof-of-concept phase II study in 9 cases","Cabon Q, Sayag D, Texier I, Navarro F, Boisgard R, Virieux-Watrelot D, Ponce F, Carozzo C.","Transl Res. 2016 Apr;170:73-88. doi: 10.1016/j.trsl.2015.12.001. Epub 2015 Dec 19.","Cabon Q","Transl Res","2016","2016/01/10","","","10.1016/j.trsl.2015.12.001"
"26286012","Application of carbon nanoparticles to mark locations for re-inspection after colonic polypectomy","Wang R, Wang Y, Li D, Yu L, Liu G, Ma J, Wang W.","Surg Endosc. 2016 Apr;30(4):1530-3. doi: 10.1007/s00464-015-4367-7. Epub 2015 Aug 19.","Wang R","Surg Endosc","2016","2015/08/20","","","10.1007/s00464-015-4367-7"
"27009101","Clinical study of harvesting lymph nodes with carbon nanoparticles in advanced gastric cancer: a prospective randomized trial","Li Z, Ao S, Bu Z, Wu A, Wu X, Shan F, Ji X, Zhang Y, Xing Z, Ji J.","World J Surg Oncol. 2016 Mar 24;14:88. doi: 10.1186/s12957-016-0835-3.","Li Z","World J Surg Oncol","2016","2016/03/25","PMC4806484","","10.1186/s12957-016-0835-3"
"26822231","Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer","Giovinazzo H, Kumar P, Sheikh A, Brooks KM, Ivanovic M, Walsh M, Caron WP, Kowalsky RJ, Song G, Whitlow A, Clarke-Pearson DL, Brewster WR, Van Le L, Zamboni BA, Bae-Jump V, Gehrig PA, Zamboni WC.","Cancer Chemother Pharmacol. 2016 Mar;77(3):565-73. doi: 10.1007/s00280-015-2945-y. Epub 2016 Jan 28.","Giovinazzo H","Cancer Chemother Pharmacol","2016","2016/01/30","","","10.1007/s00280-015-2945-y"
"26972714","Elemental analysis of histological specimens: a method to unmask nano asbestos fibers","Scimeca M, Pietroiusti A, Milano F, Anemona L, Orlandi A, Marsella LT, Bonanno E.","Eur J Histochem. 2016 Feb 1;60(1):2573. doi: 10.4081/ejh.2016.2573.","Scimeca M","Eur J Histochem","2016","2016/03/15","PMC4800250","","10.4081/ejh.2016.2573"
"26749586","Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent","Saxena A, Schneider BJ, Christos PJ, Audibert LF, Cagney JM, Scheff RJ.","Med Oncol. 2016 Feb;33(2):13. doi: 10.1007/s12032-015-0728-2. Epub 2016 Jan 9.","Saxena A","Med Oncol","2016","2016/01/11","PMC4958019","NIHMS799986","10.1007/s12032-015-0728-2"
"26698868","Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases","Siqing F, Culotta KS, Falchook GS, Hong DS, Myers AL, Zhang YP, Naing A, Janku F, Hou MM, Kurzrock R.","Cancer Chemother Pharmacol. 2016 Feb;77(2):357-64. doi: 10.1007/s00280-015-2946-x. Epub 2015 Dec 23.","Siqing F","Cancer Chemother Pharmacol","2016","2015/12/25","","","10.1007/s00280-015-2946-x"
"26296672","Initial Evaluation of the Safety of Nanoshell-Directed Photothermal Therapy in the Treatment of Prostate Disease","Stern JM, Kibanov Solomonov VV, Sazykina E, Schwartz JA, Gad SC, Goodrich GP.","Int J Toxicol. 2016 Jan-Feb;35(1):38-46. doi: 10.1177/1091581815600170. Epub 2015 Aug 21.","Stern JM","Int J Toxicol","2016","2015/08/23","","","10.1177/1091581815600170"
"26640370","Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients","Fabi A, Giannarelli D, Malaguti P, Ferretti G, Vari S, Papaldo P, Nisticò C, Caterino M, De Vita R, Mottolese M, Iacorossi L, Cognetti F.","Drug Des Devel Ther. 2015 Nov 20;9:6177-83. doi: 10.2147/DDDT.S89575. eCollection 2015.","Fabi A","Drug Des Devel Ther","2015","2015/12/08","PMC4662373","","10.2147/DDDT.S89575"
"26123189","Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients","Bertino EM, Williams TM, Nana-Sinkam SP, Shilo K, Chatterjee M, Mo X, Rahmani M, Phillips GS, Villalona-Calero MA, Otterson GA.","Clin Lung Cancer. 2015 Nov;16(6):466-74. doi: 10.1016/j.cllc.2015.05.004. Epub 2015 May 13.","Bertino EM","Clin Lung Cancer","2015","2015/07/01","PMC5076571","NIHMS805575","10.1016/j.cllc.2015.05.004"
"26118476","Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women","Pellett Madan R, Dezzutti CS, Rabe L, Hillier SL, Marrazzo J, McGowan I, Richardson BA, Herold BC; Microbicide Trials Network Biomedical Sciences working Group and the MTN 004 Protocol Team.","Am J Reprod Immunol. 2015 Oct;74(4):323-32. doi: 10.1111/aji.12412. Epub 2015 Jun 26.","Pellett Madan R","Am J Reprod Immunol","2015","2015/06/30","PMC4573238","NIHMS706529","10.1111/aji.12412"
"25761552","The role of carbon nanoparticles in identifying lymph nodes and preserving parathyroid in total endoscopic surgery of thyroid carcinoma","Wang B, Qiu NC, Zhang W, Shan CX, Jiang ZG, Liu S, Qiu M.","Surg Endosc. 2015 Oct;29(10):2914-20. doi: 10.1007/s00464-014-4020-x. Epub 2015 Mar 12.","Wang B","Surg Endosc","2015","2015/03/13","","","10.1007/s00464-014-4020-x"
"23615221","Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma","Lucas SR, Maranhão RC, Guerra JL, Coelho BM, Barboza R, Pozzi DH.","Vet Comp Oncol. 2015 Sep;13(3):184-93. doi: 10.1111/vco.12033. Epub 2013 Apr 25.","Lucas SR","Vet Comp Oncol","2015","2013/04/26","","","10.1111/vco.12033"
"25844599","Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel","Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullén A, Yachnin J, Nilsson S, Panaretakis T.","Oncotarget. 2015 Aug 28;6(25):21740-54. doi: 10.18632/oncotarget.3226.","Kharaziha P","Oncotarget","2015","2015/04/07","PMC4673300","","10.18632/oncotarget.3226"
"26056183","Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)","Rugo HS, Barry WT, Moreno-Aspitia A, Lyss AP, Cirrincione C, Leung E, Mayer EL, Naughton M, Toppmeyer D, Carey LA, Perez EA, Hudis C, Winer EP.","J Clin Oncol. 2015 Jul 20;33(21):2361-9. doi: 10.1200/JCO.2014.59.5298. Epub 2015 Jun 8.","Rugo HS","J Clin Oncol","2015","2015/06/10","PMC4500830","","10.1200/JCO.2014.59.5298"
"25989989","Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety","Shimada H, Ueda S, Saeki T, Shigekawa T, Takeuchi H, Hirokawa E, Sugitani I, Sugiyama M, Takahashi T, Matsuura K, Yamane T, Kuji I, Hasebe T, Osaki A.","Jpn J Clin Oncol. 2015 Jul;45(7):642-9. doi: 10.1093/jjco/hyv055. Epub 2015 May 19.","Shimada H","Jpn J Clin Oncol","2015","2015/05/21","","","10.1093/jjco/hyv055"
"25779953","TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer","Forero-Torres A, Varley KE, Abramson VG, Li Y, Vaklavas C, Lin NU, Liu MC, Rugo HS, Nanda R, Storniolo AM, Traina TA, Patil S, Van Poznak CH, Nangia JR, Irvin WJ Jr, Krontiras H, De Los Santos JF, Haluska P, Grizzle W, Myers RM, Wolff AC; Translational Breast Cancer Research Consortium (TBCRC).","Clin Cancer Res. 2015 Jun 15;21(12):2722-9. doi: 10.1158/1078-0432.CCR-14-2780. Epub 2015 Mar 16.","Forero-Torres A","Clin Cancer Res","2015","2015/03/18","PMC6186432","NIHMS986900","10.1158/1078-0432.CCR-14-2780"
"25779948","Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019","Paoletti C, Li Y, Muñiz MC, Kidwell KM, Aung K, Thomas DG, Brown ME, Abramson VG, Irvin WJ Jr, Lin NU, Liu MC, Nanda R, Nangia JR, Storniolo AM, Traina TA, Vaklavas C, Van Poznak CH, Wolff AC, Forero-Torres A, Hayes DF; Translational Breast Cancer Research Consortium (TBCRC).","Clin Cancer Res. 2015 Jun 15;21(12):2771-9. doi: 10.1158/1078-0432.CCR-14-2781. Epub 2015 Mar 16.","Paoletti C","Clin Cancer Res","2015","2015/03/18","PMC5521206","NIHMS877118","10.1158/1078-0432.CCR-14-2781"
"25649370","Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors","Abu-Khalaf MM, Baumgart MA, Gettinger SN, Doddamane I, Tuck DP, Hou S, Chen N, Sullivan C, Lezon-Geyda K, Zelterman D, Hatzis C, Deshpande H, Digiovanna MP, Azodi M, Schwartz PE, Harris LN.","Cancer. 2015 Jun 1;121(11):1817-26. doi: 10.1002/cncr.29254. Epub 2015 Feb 3.","Abu-Khalaf MM","Cancer","2015","2015/02/05","","","10.1002/cncr.29254"
"25579459","Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer","Tanaka S, Iwamoto M, Kimura K, Matsunami N, Morishima H, Yoshidome K, Nomura T, Morimoto T, Yamamoto D, Tsubota Y, Kobayashi T, Uchiyama K.","Clin Breast Cancer. 2015 Jun;15(3):191-6. doi: 10.1016/j.clbc.2014.12.003. Epub 2014 Dec 24.","Tanaka S","Clin Breast Cancer","2015","2015/01/13","","","10.1016/j.clbc.2014.12.003"
"25073954","A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer","Kutomi G, Ohmura T, Satomi F, Maeda H, Shima H, Kameshima H, Okazaki M, Masuoka H, Sasaki K, Hirata K.","Int J Clin Oncol. 2015 Jun;20(3):474-9. doi: 10.1007/s10147-014-0725-z. Epub 2014 Jul 30.","Kutomi G","Int J Clin Oncol","2015","2014/07/31","","","10.1007/s10147-014-0725-z"
"25898813","A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies","Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, Mackay CB, Smith HJ, Weir SJ, Wick JA, Markman M, diZerega GS, Baltezor MJ, Espinosa J, Decedue CJ.","Cancer Chemother Pharmacol. 2015 May;75(5):1075-87. doi: 10.1007/s00280-015-2737-4. Epub 2015 Apr 23.","Williamson SK","Cancer Chemother Pharmacol","2015","2015/04/23","PMC4506131","NIHMS706031","10.1007/s00280-015-2737-4"
"26081053","[Role of carbon nanoparticles in patients with thyroid carcinoma undergoing total thyroidectomy plus bilateral central neck dissection]","Wu G, Cai L, Hu J, Zhao R, Ge J, Zhao Y, Shi J, Wang Z.","Zhonghua Yi Xue Za Zhi. 2015 Mar 31;95(12):912-6.","Wu G","Zhonghua Yi Xue Za Zhi","2015","2015/06/18","","",""
"25792830","Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer","Huang L, Chen S, Yao L, Liu G, Wu J, Shao Z.","Int J Nanomedicine. 2015 Mar 11;10:1969-75. doi: 10.2147/IJN.S77000. eCollection 2015.","Huang L","Int J Nanomedicine","2015","2015/03/21","PMC4362893","","10.2147/IJN.S77000"
"25577133","Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients","Chang TC, Shiah HS, Yang CH, Yeh KH, Cheng AL, Shen BN, Wang YW, Yeh CG, Chiang NJ, Chang JY, Chen LT.","Cancer Chemother Pharmacol. 2015 Mar;75(3):579-86. doi: 10.1007/s00280-014-2671-x. Epub 2015 Jan 11.","Chang TC","Cancer Chemother Pharmacol","2015","2015/01/12","PMC4341010","","10.1007/s00280-014-2671-x"
"25516635","A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial)","Koizumi W, Morita S, Sakata Y.","Jpn J Clin Oncol. 2015 Mar;45(3):303-6. doi: 10.1093/jjco/hyu205. Epub 2014 Dec 16.","Koizumi W","Jpn J Clin Oncol","2015","2014/12/18","PMC4340275","","10.1093/jjco/hyu205"
"25524310","Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer","Pham E, Birrer MJ, Eliasof S, Garmey EG, Lazarus D, Lee CR, Man S, Matulonis UA, Peters CG, Xu P, Krasner C, Kerbel RS.","Clin Cancer Res. 2015 Feb 15;21(4):808-18. doi: 10.1158/1078-0432.CCR-14-2810. Epub 2014 Dec 18.","Pham E","Clin Cancer Res","2015","2014/12/20","","","10.1158/1078-0432.CCR-14-2810"
"25616430","A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer","Grilley-Olson JE, Keedy VL, Sandler A, Moore DT, Socinski MA, Stinchcombe TE.","Oncologist. 2015 Feb;20(2):105-6. doi: 10.1634/theoncologist.2014-0327. Epub 2015 Jan 23.","Grilley-Olson JE","Oncologist","2015","2015/01/25","PMC4319632","","10.1634/theoncologist.2014-0327"
"25492923","Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional age","Hurria A, Blanchard MS, Synold TW, Mortimer J, Chung CT, Luu T, Katheria V, Rotter AJ, Wong C, Choi A, Feng T, Ramani R, Doan CM, Brown J, Somlo G.","Oncologist. 2015 Jan;20(1):37-44. doi: 10.1634/theoncologist.2014-0202. Epub 2014 Dec 9.","Hurria A","Oncologist","2015","2014/12/11","PMC4294604","","10.1634/theoncologist.2014-0202"
"25476537","TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer","Connolly RM, Leal JP, Goetz MP, Zhang Z, Zhou XC, Jacobs LK, Mhlanga J, O JH, Carpenter J, Storniolo AM, Watkins S, Fetting JH, Miller RS, Sideras K, Jeter SC, Walsh B, Powers P, Zorzi J, Boughey JC, Davidson NE, Carey LA, Wolff AC, Khouri N, Gabrielson E, Wahl RL, Stearns V.","J Nucl Med. 2015 Jan;56(1):31-7. doi: 10.2967/jnumed.114.144741. Epub 2014 Dec 4.","Connolly RM","J Nucl Med","2015","2014/12/06","PMC4352313","NIHMS663996","10.2967/jnumed.114.144741"
"25895304","[Application of lymphatic mapping to recognize and protect parathyroid in thyroid carcinoma surgery by using carbon nanoparticles]","Chen W, Lv Y, Xie R, Xu D, Yu J.","Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Dec;28(24):1918-20, 1924.","Chen W","Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi","2014","2015/04/22","","",""
"24996128","Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure","McKiernan JM, Holder DD, Ghandour RA, Barlow LJ, Ahn JJ, Kates M, Badalato GM, Roychoudhury A, Decastro GJ, Benson MC.","J Urol. 2014 Dec;192(6):1633-8. doi: 10.1016/j.juro.2014.06.084. Epub 2014 Jul 1.","McKiernan JM","J Urol","2014","2014/07/05","","","10.1016/j.juro.2014.06.084"
"24935202","A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1-2 colorectal cancer","Yan J, Xue F, Chen H, Wu X, Zhang H, Chen G, Lu J, Cai L, Xiang G, Deng Z, Zheng Y, Zheng X, Li G.","Surg Endosc. 2014 Dec;28(12):3315-21. doi: 10.1007/s00464-014-3608-5. Epub 2014 Jun 17.","Yan J","Surg Endosc","2014","2014/06/18","","","10.1007/s00464-014-3608-5"
"25355699","Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe","Phillips E, Penate-Medina O, Zanzonico PB, Carvajal RD, Mohan P, Ye Y, Humm J, Gönen M, Kalaigian H, Schöder H, Strauss HW, Larson SM, Wiesner U, Bradbury MS.","Sci Transl Med. 2014 Oct 29;6(260):260ra149. doi: 10.1126/scitranslmed.3009524. Epub 2014 Oct 29.","Phillips E","Sci Transl Med","2014","2014/10/31","PMC4426391","NIHMS687820","10.1126/scitranslmed.3009524"
"25218300","High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine","Saito T, Wada H, Yamasaki M, Miyata H, Nishikawa H, Sato E, Kageyama S, Shiku H, Mori M, Doki Y.","Vaccine. 2014 Oct 14;32(45):5901-7. doi: 10.1016/j.vaccine.2014.09.002. Epub 2014 Sep 13.","Saito T","Vaccine","2014","2014/09/15","","","10.1016/j.vaccine.2014.09.002"
"24893049","Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging","Thoeny HC, Froehlich JM, Triantafyllou M, Huesler J, Bains LJ, Vermathen P, Fleischmann A, Studer UE.","Radiology. 2014 Oct;273(1):125-35. doi: 10.1148/radiol.14132921. Epub 2014 Jun 2.","Thoeny HC","Radiology","2014","2014/06/04","","","10.1148/radiol.14132921"
"25049380","Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, Chmielowski B, Ribas A, Davis ME, Yen Y.","Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11449-54. doi: 10.1073/pnas.1411393111. Epub 2014 Jul 21.","Zuckerman JE","Proc Natl Acad Sci U S A","2014","2014/07/23","PMC4128111","","10.1073/pnas.1411393111"
"24906423","A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer","Ahn HK, Jung M, Sym SJ, Shin DB, Kang SM, Kyung SY, Park JW, Jeong SH, Cho EK.","Cancer Chemother Pharmacol. 2014 Aug;74(2):277-82. doi: 10.1007/s00280-014-2498-5. Epub 2014 Jun 7.","Ahn HK","Cancer Chemother Pharmacol","2014","2014/06/08","PMC4112044","","10.1007/s00280-014-2498-5"
"24743052","Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma","Alrwas A, Papadopoulos NE, Cain S, Patel SP, Kim KB, Deburr TL, Bassett R Jr, Hwu WJ, Bedikian AY, Davies MA, Woodman SE, Hwu P.","Melanoma Res. 2014 Aug;24(4):342-8. doi: 10.1097/CMR.0000000000000062.","Alrwas A","Melanoma Res","2014","2014/04/19","PMC4278368","NIHMS650432","10.1097/CMR.0000000000000062"
"24703985","Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer","Mrózek E, Layman R, Ramaswamy B, Lustberg M, Vecchione A, Knopp MV, Shapiro CL.","Clin Breast Cancer. 2014 Aug;14(4):228-34. doi: 10.1016/j.clbc.2014.02.005. Epub 2014 Feb 20.","Mrózek E","Clin Breast Cancer","2014","2014/04/08","PMC4104207","NIHMS596977","10.1016/j.clbc.2014.02.005"
"24716542","Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer","Sasaki Y, Nishina T, Yasui H, Goto M, Muro K, Tsuji A, Koizumi W, Toh Y, Hara T, Miyata Y.","Cancer Sci. 2014 Jul;105(7):812-7. doi: 10.1111/cas.12419. Epub 2014 Jul 7.","Sasaki Y","Cancer Sci","2014","2014/04/11","PMC4317911","","10.1111/cas.12419"
"25028536","Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state","Jang K, Yoon S, Kim SE, Cho JY, Yoon SH, Lim KS, Yu KS, Jang IJ, Lee H.","Drug Des Devel Ther. 2014 Jun 25;8:851-8. doi: 10.2147/DDDT.S62176. eCollection 2014.","Jang K","Drug Des Devel Ther","2014","2014/07/17","PMC4077389","","10.2147/DDDT.S62176"
"24859954","[Application of subserosal injection of carbon nanoparticles via infusion needle to label lymph nodes in laparoscopic radical gastrectomy]","Chen H, Wang Y, Xue F, Yu J, Hu Y, Liu H, Yan J, Li G.","Zhonghua Wei Chang Wai Ke Za Zhi. 2014 May;17(5):457-60.","Chen H","Zhonghua Wei Chang Wai Ke Za Zhi","2014","2014/05/27","","",""
"24503408","In vivo intraocular distribution and safety of periocular nanoparticle carboplatin for treatment of advanced retinoblastoma in humans","Kalita D, Shome D, Jain VG, Chadha K, Bellare JR.","Am J Ophthalmol. 2014 May;157(5):1109-15. doi: 10.1016/j.ajo.2014.01.027. Epub 2014 Feb 4.","Kalita D","Am J Ophthalmol","2014","2014/02/08","","","10.1016/j.ajo.2014.01.027"
"24484967","The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope","Thill M, Kurylcio A, Welter R, van Haasteren V, Grosse B, Berclaz G, Polkowski W, Hauser N.","Breast. 2014 Apr;23(2):175-9. doi: 10.1016/j.breast.2014.01.004. Epub 2014 Jan 29.","Thill M","Breast","2014","2014/02/04","","","10.1016/j.breast.2014.01.004"
"24672237","Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer","Sun S, Tang L, Zhang J, Lv F, Wang Z, Wang L, Zhang Q, Zheng C, Qiu L, Jia Z, Lu Y, Liu G, Shao Z, Wang B, Hu X.","Int J Nanomedicine. 2014 Mar 19;9:1443-52. doi: 10.2147/IJN.S58275. eCollection 2014.","Sun S","Int J Nanomedicine","2014","2014/03/28","PMC3964033","","10.2147/IJN.S58275"
"24422996","Bioadhesive lipid compositions: self-assembly structures, functionality, and medical applications","Barauskas J, Christerson L, Wadsäter M, Lindström F, Lindqvist AK, Tiberg F.","Mol Pharm. 2014 Mar 3;11(3):895-903. doi: 10.1021/mp400552u. Epub 2014 Jan 27.","Barauskas J","Mol Pharm","2014","2014/01/16","","","10.1021/mp400552u"
"24266266","Preoperative colonic lesion localization with charcoal nanoparticle tattooing for laparoscopic colorectal surgery","Wang W, Wang R, Wang Y, Yu L, Li D, Huang S, Ma J, Lin N, Yang W, Chen X, Liu B, Lv R, Liao L.","J Biomed Nanotechnol. 2013 Dec;9(12):2123-5. doi: 10.1166/jbn.2013.1767.","Wang W","J Biomed Nanotechnol","2013","2013/11/26","","","10.1166/jbn.2013.1767"
"24163324","Protection of parathyroid function using carbon nanoparticles during thyroid surgery","Huang K, Luo D, Huang M, Long M, Peng X, Li H.","Otolaryngol Head Neck Surg. 2013 Dec;149(6):845-50. doi: 10.1177/0194599813509779. Epub 2013 Oct 25.","Huang K","Otolaryngol Head Neck Surg","2013","2013/10/29","","","10.1177/0194599813509779"
"24013936","Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer","Ho C, Davies AM, Sangha RS, Lau D, Lara P Jr, Chew HK, Beckett L, Mack PC, Riess JW, Gandara DR.","Invest New Drugs. 2013 Dec;31(6):1587-91. doi: 10.1007/s10637-013-0024-y. Epub 2013 Sep 8.","Ho C","Invest New Drugs","2013","2013/09/10","PMC4562389","NIHMS719861","10.1007/s10637-013-0024-y"
"23989300","Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors","Wu H, Infante JR, Keedy VL, Jones SF, Chan E, Bendell JC, Lee W, Zamboni BA, Ikeda S, Kodaira H, Rothenberg ML, Burris HA 3rd, Zamboni WC.","Eur J Clin Pharmacol. 2013 Dec;69(12):2073-81. doi: 10.1007/s00228-013-1580-y. Epub 2013 Aug 30.","Wu H","Eur J Clin Pharmacol","2013","2013/08/31","","","10.1007/s00228-013-1580-y"
"23916692","Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer","Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, Vermathen P, Fleischmann A, Thoeny HC.","Eur Urol. 2013 Dec;64(6):953-60. doi: 10.1016/j.eururo.2013.07.032. Epub 2013 Jul 30.","Birkhäuser FD","Eur Urol","2013","2013/08/07","","","10.1016/j.eururo.2013.07.032"
"23907766","Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia","Silverman JA, Reynolds L, Deitcher SR.","J Clin Pharmacol. 2013 Nov;53(11):1139-45. doi: 10.1002/jcph.155. Epub 2013 Aug 17.","Silverman JA","J Clin Pharmacol","2013","2013/08/03","","","10.1002/jcph.155"
"23990473","Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids","Wu CY, Martel J, Cheng WY, He CC, Ojcius DM, Young JD.","J Biol Chem. 2013 Oct 18;288(42):30571-30584. doi: 10.1074/jbc.M113.492157. Epub 2013 Aug 29.","Wu CY","J Biol Chem","2013","2013/08/31","PMC3798528","","10.1074/jbc.M113.492157"
"24089446","Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial","Gonzalez-Angulo AM, Meric-Bernstam F, Chawla S, Falchook G, Hong D, Akcakanat A, Chen H, Naing A, Fu S, Wheler J, Moulder S, Helgason T, Li S, Elias I, Desai N, Kurzrock R.","Clin Cancer Res. 2013 Oct 1;19(19):5474-84. doi: 10.1158/1078-0432.CCR-12-3110.","Gonzalez-Angulo AM","Clin Cancer Res","2013","2013/10/04","PMC3935482","NIHMS549052","10.1158/1078-0432.CCR-12-3110"
"24014084","High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles","Chiodo F, Marradi M, Tefsen B, Snippe H, van Die I, Penadés S.","PLoS One. 2013 Aug 27;8(8):e73027. doi: 10.1371/journal.pone.0073027. eCollection 2013.","Chiodo F","PLoS One","2013","2013/09/10","PMC3754922","","10.1371/journal.pone.0073027"
"23829890","Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer","Seidman AD, Conlin AK, Bach A, Moynahan ME, Lake D, Forero A, Wright GS, Hackney MH, Clawson A, Norton L, Hudis CA.","Clin Breast Cancer. 2013 Aug;13(4):239-246.e1. doi: 10.1016/j.clbc.2013.02.008.","Seidman AD","Clin Breast Cancer","2013","2013/07/09","","","10.1016/j.clbc.2013.02.008"
"23763920","Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia","Wetzler M, Thomas DA, Wang ES, Shepard R, Ford LA, Heffner TL, Parekh S, Andreeff M, O'Brien S, Kantarjian HM.","Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):430-4. doi: 10.1016/j.clml.2013.03.015. Epub 2013 Jun 10.","Wetzler M","Clin Lymphoma Myeloma Leuk","2013","2013/06/15","PMC3737573","NIHMS494299","10.1016/j.clml.2013.03.015"
"23397498","First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies","Weiss GJ, Chao J, Neidhart JD, Ramanathan RK, Bassett D, Neidhart JA, Choi CHJ, Chow W, Chung V, Forman SJ, Garmey E, Hwang J, Kalinoski DL, Koczywas M, Longmate J, Melton RJ, Morgan R, Oliver J, Peterkin JJ, Ryan JL, Schluep T, Synold TW, Twardowski P, Davis ME, Yen Y.","Invest New Drugs. 2013 Aug;31(4):986-1000. doi: 10.1007/s10637-012-9921-8. Epub 2013 Feb 9.","Weiss GJ","Invest New Drugs","2013","2013/02/12","PMC3774600","NIHMS508697","10.1007/s10637-012-9921-8"
"23706985","Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study","Ko YJ, Canil CM, Mukherjee SD, Winquist E, Elser C, Eisen A, Reaume MN, Zhang L, Sridhar SS.","Lancet Oncol. 2013 Jul;14(8):769-76. doi: 10.1016/S1470-2045(13)70162-1. Epub 2013 May 22.","Ko YJ","Lancet Oncol","2013","2013/05/28","","","10.1016/S1470-2045(13)70162-1"
"23703909","A Raman-based endoscopic strategy for multiplexed molecular imaging","Zavaleta CL, Garai E, Liu JT, Sensarn S, Mandella MJ, Van de Sompel D, Friedland S, Van Dam J, Contag CH, Gambhir SS.","Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):E2288-97. doi: 10.1073/pnas.1211309110. Epub 2013 May 23.","Zavaleta CL","Proc Natl Acad Sci U S A","2013","2013/05/25","PMC3690865","","10.1073/pnas.1211309110"
"23534988","Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain","Alba E, Ciruelos E, López R, López-Vega JM, Lluch A, Martín M, Muñoz M, Sánchez-Rovira P, Seguí MÁ, Liria MR, Pérez-Alcántara F.","Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):381-91. doi: 10.1586/erp.13.18. Epub 2013 Mar 28.","Alba E","Expert Rev Pharmacoecon Outcomes Res","2013","2013/03/29","","","10.1586/erp.13.18"
"23406728","A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma","Roy AC, Park SR, Cunningham D, Kang YK, Chao Y, Chen LT, Rees C, Lim HY, Tabernero J, Ramos FJ, Kujundzic M, Cardic MB, Yeh CG, de Gramont A.","Ann Oncol. 2013 Jun;24(6):1567-73. doi: 10.1093/annonc/mdt002. Epub 2013 Feb 13.","Roy AC","Ann Oncol","2013","2013/02/15","","","10.1093/annonc/mdt002"
"23176568","A multicenter phase II randomized study of Cremophor-free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline","Ranade AA, Bapsy PP, Nag S, Raghunadharao D, Raina V, Advani SH, Patil S, Maru A, Gangadharan VP, Goswami C, Sekhon JS, Sambasivaiah K, Parikh P, Bakshi A, Mohapatra R.","Asia Pac J Clin Oncol. 2013 Jun;9(2):176-81. doi: 10.1111/ajco.12035. Epub 2012 Nov 26.","Ranade AA","Asia Pac J Clin Oncol","2013","2012/11/27","","","10.1111/ajco.12035"
"23659317","Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients","Tang LC, Wang BY, Sun S, Zhang J, Jia Z, Lu YH, Di GH, Shao ZM, Hu XC.","BMC Cancer. 2013 May 9;13:232. doi: 10.1186/1471-2407-13-232.","Tang LC","BMC Cancer","2013","2013/05/11","PMC3658926","","10.1186/1471-2407-13-232"
"23609015","Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors","Senzer N, Nemunaitis J, Nemunaitis D, Bedell C, Edelman G, Barve M, Nunan R, Pirollo KF, Rait A, Chang EH.","Mol Ther. 2013 May;21(5):1096-103. doi: 10.1038/mt.2013.32. Epub 2013 Apr 23.","Senzer N","Mol Ther","2013","2013/04/24","PMC3666630","","10.1038/mt.2013.32"
"23564374","Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors","Saif MW, Erlichman C, Dragovich T, Mendelson D, Toft D, Burrows F, Storgard C, Von Hoff D.","Cancer Chemother Pharmacol. 2013 May;71(5):1345-55. doi: 10.1007/s00280-013-2134-9. Epub 2013 Apr 6.","Saif MW","Cancer Chemother Pharmacol","2013","2013/04/09","","","10.1007/s00280-013-2134-9"
"23563958","Nab-paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis","O'Shaughnessy J, Gradishar WJ, Bhar P, Iglesias J.","Breast Cancer Res Treat. 2013 Apr;138(3):829-37. doi: 10.1007/s10549-013-2447-8. Epub 2013 Apr 6.","O'Shaughnessy J","Breast Cancer Res Treat","2013","2013/04/09","PMC3631516","","10.1007/s10549-013-2447-8"
"23358650","First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement","Tabernero J, Shapiro GI, LoRusso PM, Cervantes A, Schwartz GK, Weiss GJ, Paz-Ares L, Cho DC, Infante JR, Alsina M, Gounder MM, Falzone R, Harrop J, White AC, Toudjarska I, Bumcrot D, Meyers RE, Hinkle G, Svrzikapa N, Hutabarat RM, Clausen VA, Cehelsky J, Nochur SV, Gamba-Vitalo C, Vaishnaw AK, Sah DW, Gollob JA, Burris HA 3rd.","Cancer Discov. 2013 Apr;3(4):406-17. doi: 10.1158/2159-8290.CD-12-0429. Epub 2013 Jan 28.","Tabernero J","Cancer Discov","2013","2013/01/30","","","10.1158/2159-8290.CD-12-0429"
"23443188","Therapeutic effects of acoustic cavitation in the presence of gold nanoparticles on a colon tumor model","Sazgarnia A, Shanei A, Taheri AR, Meibodi NT, Eshghi H, Attaran N, Shanei MM.","J Ultrasound Med. 2013 Mar;32(3):475-83. doi: 10.7863/jum.2013.32.3.475.","Sazgarnia A","J Ultrasound Med","2013","2013/02/28","","","10.7863/jum.2013.32.3.475"
"23169518","High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia","O'Brien S, Schiller G, Lister J, Damon L, Goldberg S, Aulitzky W, Ben-Yehuda D, Stock W, Coutre S, Douer D, Heffner LT, Larson M, Seiter K, Smith S, Assouline S, Kuriakose P, Maness L, Nagler A, Rowe J, Schaich M, Shpilberg O, Yee K, Schmieder G, Silverman JA, Thomas D, Deitcher SR, Kantarjian H.","J Clin Oncol. 2013 Feb 20;31(6):676-83. doi: 10.1200/JCO.2012.46.2309. Epub 2012 Nov 19.","O'Brien S","J Clin Oncol","2013","2012/11/22","PMC4979201","","10.1200/JCO.2012.46.2309"
"23278862","Deposition of superparamagnetic iron-oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection","Johnson L, Pinder SE, Douek M.","Histopathology. 2013 Feb;62(3):481-6. doi: 10.1111/his.12019. Epub 2012 Dec 21.","Johnson L","Histopathology","2013","2013/01/03","","","10.1111/his.12019"
"23224144","Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen","Yardley DA, Hart L, Bosserman L, Salleh MN, Waterhouse DM, Hagan MK, Richards P, DeSilvio ML, Mahoney JM, Nagarwala Y.","Breast Cancer Res Treat. 2013 Jan;137(2):457-64. doi: 10.1007/s10549-012-2341-9. Epub 2012 Dec 8.","Yardley DA","Breast Cancer Res Treat","2013","2012/12/11","PMC3539071","","10.1007/s10549-012-2341-9"
"23153506","Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study","Mamot C, Ritschard R, Wicki A, Stehle G, Dieterle T, Bubendorf L, Hilker C, Deuster S, Herrmann R, Rochlitz C.","Lancet Oncol. 2012 Dec;13(12):1234-41. doi: 10.1016/S1470-2045(12)70476-X. Epub 2012 Nov 13.","Mamot C","Lancet Oncol","2012","2012/11/17","","","10.1016/S1470-2045(12)70476-X"
"22986144","Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study","Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM.","Gynecol Oncol. 2012 Dec;127(3):451-5. doi: 10.1016/j.ygyno.2012.09.008. Epub 2012 Sep 14.","Alberts DS","Gynecol Oncol","2012","2012/09/19","PMC4459779","NIHMS432821","10.1016/j.ygyno.2012.09.008"
"22948779","A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticle-epirubicin in patients with breast cancer","Yang Q, Wang XD, Chen J, Tian CX, Li HJ, Chen YJ, Lv Q.","Tumour Biol. 2012 Dec;33(6):2341-8. doi: 10.1007/s13277-012-0496-y. Epub 2012 Sep 5.","Yang Q","Tumour Biol","2012","2012/09/06","","","10.1007/s13277-012-0496-y"
"23155345","Colorectal cancer lymph node staining by activated carbon nanoparticles suspension in vivo or methylene blue in vitro","Cai HK, He HF, Tian W, Zhou MQ, Hu Y, Deng YC.","World J Gastroenterol. 2012 Nov 14;18(42):6148-54. doi: 10.3748/wjg.v18.i42.6148.","Cai HK","World J Gastroenterol","2012","2012/11/17","PMC3496893","","10.3748/wjg.v18.i42.6148"
"22806397","Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients","Goldinger SM, Dummer R, Baumgaertner P, Mihic-Probst D, Schwarz K, Hammann-Haenni A, Willers J, Geldhof C, Prior JO, Kündig TM, Michielin O, Bachmann MF, Speiser DE.","Eur J Immunol. 2012 Nov;42(11):3049-61. doi: 10.1002/eji.201142361. Epub 2012 Aug 28.","Goldinger SM","Eur J Immunol","2012","2012/07/19","PMC3549564","","10.1002/eji.201142361"
"21728023","Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer","Kato K, Chin K, Yoshikawa T, Yamaguchi K, Tsuji Y, Esaki T, Sakai K, Kimura M, Hamaguchi T, Shimada Y, Matsumura Y, Ikeda R.","Invest New Drugs. 2012 Aug;30(4):1621-7. doi: 10.1007/s10637-011-9709-2. Epub 2011 Jul 5.","Kato K","Invest New Drugs","2012","2011/07/06","","","10.1007/s10637-011-9709-2"
"21537886","Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer","Okamoto I, Yamamoto N, Kubota K, Ohe Y, Nogami N, Murakami H, Yamaya H, Ono K, Nakagawa K.","Invest New Drugs. 2012 Jun;30(3):1132-7. doi: 10.1007/s10637-011-9674-9. Epub 2011 May 3.","Okamoto I","Invest New Drugs","2012","2011/05/04","","","10.1007/s10637-011-9674-9"
"21359953","Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib","Kaklamani VG, Siziopikou K, Scholtens D, Lacouture M, Gordon J, Uthe R, Meservey C, Hansen N, Khan SA, Jeruss JS, Bethke K, Cianfrocca M, Rosen S, Von Roenn J, Wayne J, Parimi V, Jovanovic B, Gradishar W.","Breast Cancer Res Treat. 2012 Apr;132(3):833-42. doi: 10.1007/s10549-011-1411-8. Epub 2011 Feb 27.","Kaklamani VG","Breast Cancer Res Treat","2012","2011/03/02","","","10.1007/s10549-011-1411-8"
"21174224","A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate","Bruce JY, Eickhoff J, Pili R, Logan T, Carducci M, Arnott J, Treston A, Wilding G, Liu G.","Invest New Drugs. 2012 Apr;30(2):794-802. doi: 10.1007/s10637-010-9618-9. Epub 2010 Dec 22.","Bruce JY","Invest New Drugs","2012","2010/12/22","PMC3191229","NIHMS299941","10.1007/s10637-010-9618-9"
"22245189","A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy","Myrehaug S, Chan G, Craig T, Weinberg V, Cheng C, Roach M 3rd, Cheung P, Sahgal A.","Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e657-62. doi: 10.1016/j.ijrobp.2011.09.006. Epub 2012 Jan 13.","Myrehaug S","Int J Radiat Oncol Biol Phys","2012","2012/01/17","","","10.1016/j.ijrobp.2011.09.006"
"21853310","Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer","Ando M, Yonemori K, Katsumata N, Shimizu C, Hirata T, Yamamoto H, Hashimoto K, Yunokawa M, Tamura K, Fujiwara Y.","Cancer Chemother Pharmacol. 2012 Feb;69(2):457-65. doi: 10.1007/s00280-011-1726-5. Epub 2011 Aug 19.","Ando M","Cancer Chemother Pharmacol","2012","2011/08/20","","","10.1007/s00280-011-1726-5"
"22558101","Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans","Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, Nunez MI, Wistuba II, Erasmus JJ, Hicks ME, Grimm EA, Reuben JM, Baladandayuthapani V, Templeton NS, McMannis JD, Roth JA.","PLoS One. 2012;7(4):e34833. doi: 10.1371/journal.pone.0034833. Epub 2012 Apr 25.","Lu C","PLoS One","2012","2012/05/05","PMC3338819","","10.1371/journal.pone.0034833"
"22121824","Effect of humidity on nanoparticle-based chemiresistors: a comparison between synthetic and real-world samples","Konvalina G, Haick H.","ACS Appl Mater Interfaces. 2012 Jan;4(1):317-25. doi: 10.1021/am2013695. Epub 2011 Dec 15.","Konvalina G","ACS Appl Mater Interfaces","2012","2011/11/30","","","10.1021/am2013695"
"21603867","Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers","Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T.","Cancer Chemother Pharmacol. 2012 Jan;69(1):65-70. doi: 10.1007/s00280-011-1673-1. Epub 2011 May 21.","Kanai M","Cancer Chemother Pharmacol","2012","2011/05/24","","","10.1007/s00280-011-1673-1"
"21590446","Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients","La-Beck NM, Zamboni BA, Gabizon A, Schmeeda H, Amantea M, Gehrig PA, Zamboni WC.","Cancer Chemother Pharmacol. 2012 Jan;69(1):43-50. doi: 10.1007/s00280-011-1664-2. Epub 2011 May 18.","La-Beck NM","Cancer Chemother Pharmacol","2012","2011/05/19","","","10.1007/s00280-011-1664-2"
"20499131","A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)","Harrison MR, Hahn NM, Pili R, Oh WK, Hammers H, Sweeney C, Kim K, Perlman S, Arnott J, Sidor C, Wilding G, Liu G.","Invest New Drugs. 2011 Dec;29(6):1465-74. doi: 10.1007/s10637-010-9455-x. Epub 2010 May 25.","Harrison MR","Invest New Drugs","2011","2010/05/26","PMC3042040","NIHMS235440","10.1007/s10637-010-9455-x"
"22030751","Preclinical and clinical evaluation of intraductally administered agents in early breast cancer","Stearns V, Mori T, Jacobs LK, Khouri NF, Gabrielson E, Yoshida T, Kominsky SL, Huso DL, Jeter S, Powers P, Tarpinian K, Brown RJ, Lange JR, Rudek MA, Zhang Z, Tsangaris TN, Sukumar S.","Sci Transl Med. 2011 Oct 26;3(106):106ra108. doi: 10.1126/scitranslmed.3002368.","Stearns V","Sci Transl Med","2011","2011/10/28","PMC3616888","NIHMS438881","10.1126/scitranslmed.3002368"
"21843943","Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: a post-hoc analysis","Aapro M, Tjulandin S, Bhar P, Gradishar W.","Breast. 2011 Oct;20(5):468-74. doi: 10.1016/j.breast.2011.07.005. Epub 2011 Aug 16.","Aapro M","Breast","2011","2011/08/17","","","10.1016/j.breast.2011.07.005"
"21816044","Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial)","Eckes J, Schmah O, Siebers JW, Groh U, Zschiedrich S, Rautenberg B, Hasenburg A, Jansen M, Hug MJ, Winkler K, Pütz G.","BMC Cancer. 2011 Aug 4;11:337. doi: 10.1186/1471-2407-11-337.","Eckes J","BMC Cancer","2011","2011/08/06","PMC3175222","","10.1186/1471-2407-11-337"
"21680003","A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Guérin refractory nonmuscle invasive bladder cancer","McKiernan JM, Barlow LJ, Laudano MA, Mann MJ, Petrylak DP, Benson MC.","J Urol. 2011 Aug;186(2):448-51. doi: 10.1016/j.juro.2011.03.129. Epub 2011 Jun 15.","McKiernan JM","J Urol","2011","2011/06/18","","","10.1016/j.juro.2011.03.129"
"21571911","Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activity","Fu S, Naing A, Moulder SL, Culotta KS, Madoff DC, Ng CS, Madden TL, Falchook GS, Hong DS, Kurzrock R.","Mol Cancer Ther. 2011 Jul;10(7):1300-7. doi: 10.1158/1535-7163.MCT-11-0259. Epub 2011 May 13.","Fu S","Mol Cancer Ther","2011","2011/05/17","","","10.1158/1535-7163.MCT-11-0259"
"21497382","A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study","Coleman RL, Brady WE, McMeekin DS, Rose PG, Soper JT, Lentz SS, Hoffman JS, Shahin MS.","Gynecol Oncol. 2011 Jul;122(1):111-5. doi: 10.1016/j.ygyno.2011.03.036. Epub 2011 Apr 15.","Coleman RL","Gynecol Oncol","2011","2011/04/19","PMC3104117","NIHMS287811","10.1016/j.ygyno.2011.03.036"
"20845061","Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme","Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A.","J Neurooncol. 2011 Jun;103(2):317-24. doi: 10.1007/s11060-010-0389-0. Epub 2010 Sep 16.","Maier-Hauff K","J Neurooncol","2011","2010/09/17","PMC3097345","","10.1007/s11060-010-0389-0"
"21350003","A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer","McArthur HL, Rugo H, Nulsen B, Hawks L, Grothusen J, Melisko M, Moasser M, Paulson M, Traina T, Patil S, Zhou Q, Steingart R, Dang C, Morrow M, Cordeiro P, Fornier M, Park J, Seidman A, Lake D, Gilewski T, Theodoulou M, Modi S, D'Andrea G, Sklarin N, Robson M, Moynahan ME, Sugarman S, Sealey JE, Laragh JH, Merali C, Norton L, Hudis CA, Dickler MN.","Clin Cancer Res. 2011 May 15;17(10):3398-407. doi: 10.1158/1078-0432.CCR-10-1969. Epub 2011 Feb 24.","McArthur HL","Clin Cancer Res","2011","2011/02/26","PMC4994894","NIHMS453216","10.1158/1078-0432.CCR-10-1969"
"21505455","Diagnosis of head-and-neck cancer from exhaled breath","Hakim M, Billan S, Tisch U, Peng G, Dvrokind I, Marom O, Abdah-Bortnyak R, Kuten A, Haick H.","Br J Cancer. 2011 May 10;104(10):1649-55. doi: 10.1038/bjc.2011.128. Epub 2011 Apr 19.","Hakim M","Br J Cancer","2011","2011/04/21","PMC3101906","","10.1038/bjc.2011.128"
"21569998","A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer","Mirtsching B, Cosgriff T, Harker G, Keaton M, Chidiac T, Min M.","Clin Breast Cancer. 2011 Apr;11(2):121-8. doi: 10.1016/j.clbc.2011.03.007. Epub 2011 Apr 11.","Mirtsching B","Clin Breast Cancer","2011","2011/05/17","","","10.1016/j.clbc.2011.03.007"
"22072863","Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs","Axiak SM, Selting KA, Decedue CJ, Henry CJ, Tate D, Howell J, Bilof KJ, Kim DY.","Int J Nanomedicine. 2011;6:2205-12. doi: 10.2147/IJN.S24823. Epub 2011 Oct 11.","Axiak SM","Int J Nanomedicine","2011","2011/11/11","PMC3205122","","10.2147/IJN.S24823"
"20876255","Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine","Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L.","Clin Cancer Res. 2010 Dec 15;16(24):6139-49. doi: 10.1158/1078-0432.CCR-10-0978. Epub 2010 Sep 27.","Libutti SK","Clin Cancer Res","2010","2010/09/30","PMC3004980","NIHMS240946","10.1158/1078-0432.CCR-10-0978"
"20721962","Activated carbon nanoparticles or methylene blue as tracer during video-assisted thoracic surgery for lung cancer can help pathologist find the detected lymph nodes","He J, Li S, Shao W, Wang D, Chen M, Yin W, Wang W, Gu Y, Zhong B.","J Surg Oncol. 2010 Nov 1;102(6):676-82. doi: 10.1002/jso.21684.","He J","J Surg Oncol","2010","2010/08/20","","","10.1002/jso.21684"
"20943763","Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors","Hamaguchi T, Doi T, Eguchi-Nakajima T, Kato K, Yamada Y, Shimada Y, Fuse N, Ohtsu A, Matsumoto S, Takanashi M, Matsumura Y.","Clin Cancer Res. 2010 Oct 15;16(20):5058-66. doi: 10.1158/1078-0432.CCR-10-0387. Epub 2010 Oct 13.","Hamaguchi T","Clin Cancer Res","2010","2010/10/15","","","10.1158/1078-0432.CCR-10-0387"
"20842051","Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients","Speiser DE, Schwarz K, Baumgaertner P, Manolova V, Devevre E, Sterry W, Walden P, Zippelius A, Conzett KB, Senti G, Voelter V, Cerottini JP, Guggisberg D, Willers J, Geldhof C, Romero P, Kündig T, Knuth A, Dummer R, Trefzer U, Bachmann MF.","J Immunother. 2010 Oct;33(8):848-58. doi: 10.1097/CJI.0b013e3181f1d614.","Speiser DE","J Immunother","2010","2010/09/16","","","10.1097/CJI.0b013e3181f1d614"
"19575282","High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results","Kimura K, Tanigawa N, Matsuki M, Nohara T, Iwamoto M, Sumiyoshi K, Tanaka S, Takahashi Y, Narumi Y.","Breast Cancer. 2010 Oct;17(4):241-6. doi: 10.1007/s12282-009-0143-7. Epub 2009 Jul 3.","Kimura K","Breast Cancer","2010","2009/07/04","","","10.1007/s12282-009-0143-7"
"20658263","A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer","Yardley D, Burris H 3rd, Peacock N, Raefsky E, Melnik M, Inhorn R, Shipley D, Hainsworth J.","Breast Cancer Res Treat. 2010 Sep;123(2):471-5. doi: 10.1007/s10549-010-1047-0. Epub 2010 Jul 24.","Yardley D","Breast Cancer Res Treat","2010","2010/07/27","","","10.1007/s10549-010-1047-0"
"20585851","Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer","Lobo C, Lopes G, Baez O, Castrellon A, Ferrell A, Higgins C, Hurley E, Hurley J, Reis I, Richman S, Seo P, Silva O, Slingerland J, Tukia K, Welsh C, Glück S.","Breast Cancer Res Treat. 2010 Sep;123(2):427-35. doi: 10.1007/s10549-010-1002-0. Epub 2010 Jun 29.","Lobo C","Breast Cancer Res Treat","2010","2010/06/30","","","10.1007/s10549-010-1002-0"
"20705560","Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer","Conlin AK, Seidman AD, Bach A, Lake D, Dickler M, D'Andrea G, Traina T, Danso M, Brufsky AM, Saleh M, Clawson A, Hudis CA.","Clin Breast Cancer. 2010 Aug 1;10(4):281-7. doi: 10.3816/CBC.2010.n.036.","Conlin AK","Clin Breast Cancer","2010","2010/08/14","PMC3883128","NIHMS324245","10.3816/CBC.2010.n.036"
"20133335","Phase I and pharmacokinetic study of ABI-007, albumin-bound paclitaxel, administered every 3 weeks in Japanese patients with solid tumors","Yamada K, Yamamoto N, Yamada Y, Mukohara T, Minami H, Tamura T.","Jpn J Clin Oncol. 2010 May;40(5):404-11. doi: 10.1093/jjco/hyp192. Epub 2010 Feb 4.","Yamada K","Jpn J Clin Oncol","2010","2010/02/06","PMC2862657","","10.1093/jjco/hyp192"
"20098330","Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease","Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.","Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b.","Ichikawa T","Invest Radiol","2010","2010/01/26","","","10.1097/RLI.0b013e3181caea5b"
"20133263","A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer","Robidoux A, Buzdar AU, Quinaux E, Jacobs S, Rastogi P, Fourchotte V, Younan RJ, Pajon ER, Shalaby IA, Desai AM, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Wolmark N.","Clin Breast Cancer. 2010 Feb;10(1):81-6. doi: 10.3816/CBC.2010.n.011.","Robidoux A","Clin Breast Cancer","2010","2010/02/06","","","10.3816/CBC.2010.n.011"
"19495958","nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial","Dranitsaris G, Coleman R, Gradishar W.","Breast Cancer Res Treat. 2010 Feb;119(3):717-24. doi: 10.1007/s10549-009-0424-z. Epub 2009 Jun 3.","Dranitsaris G","Breast Cancer Res Treat","2010","2009/06/05","","","10.1007/s10549-009-0424-z"
"20160682","Comparison of a 3-D multi-group SN particle transport code with Monte Carlo for intracavitary brachytherapy of the cervix uteri","Gifford KA, Wareing TA, Failla G, Horton JL, Eifel PJ, Mourtada F.","J Appl Clin Med Phys. 2009 Dec 3;11(1):3103. doi: 10.1120/jacmp.v11i1.3103.","Gifford KA","J Appl Clin Med Phys","2009","2010/02/18","PMC5719779","","10.1120/jacmp.v11i1.3103"
"19887966","Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer","Reynolds C, Barrera D, Jotte R, Spira AI, Weissman C, Boehm KA, Pritchard S, Asmar L.","J Thorac Oncol. 2009 Dec;4(12):1537-43. doi: 10.1097/JTO.0b013e3181c0a2f4.","Reynolds C","J Thorac Oncol","2009","2009/11/06","","","10.1097/JTO.0b013e3181c0a2f4"
"19708032","Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia","Thomas DA, Kantarjian HM, Stock W, Heffner LT, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Pierce S, Lu B, Deitcher SR, O'Brien S.","Cancer. 2009 Dec 1;115(23):5490-8. doi: 10.1002/cncr.24632.","Thomas DA","Cancer","2009","2009/08/27","PMC4458381","NIHMS676514","10.1002/cncr.24632"
"19523421","A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma","Zhou Q, Sun X, Zeng L, Liu J, Zhang Z.","Nanomedicine. 2009 Dec;5(4):419-23. doi: 10.1016/j.nano.2009.01.009. Epub 2009 Feb 13.","Zhou Q","Nanomedicine","2009","2009/06/16","","","10.1016/j.nano.2009.01.009"
"19706807","A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies","Chien AJ, Illi JA, Ko AH, Korn WM, Fong L, Chen LM, Kashani-Sabet M, Ryan CJ, Rosenberg JE, Dubey S, Small EJ, Jahan TM, Hylton NM, Yeh BM, Huang Y, Koch KM, Moasser MM.","Clin Cancer Res. 2009 Sep 1;15(17):5569-75. doi: 10.1158/1078-0432.CCR-09-0522. Epub 2009 Aug 25.","Chien AJ","Clin Cancer Res","2009","2009/08/27","PMC3029022","NIHMS263170","10.1158/1078-0432.CCR-09-0522"
"19532136","Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcoma","Chawla SP, Chua VS, Fernandez L, Quon D, Saralou A, Blackwelder WC, Hall FL, Gordon EM.","Mol Ther. 2009 Sep;17(9):1651-7. doi: 10.1038/mt.2009.126. Epub 2009 Jun 16.","Chawla SP","Mol Ther","2009","2009/06/18","PMC2835268","","10.1038/mt.2009.126"
"19559353","Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy","Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU, Kaufman DS, Islam T, Guimaraes AR, Weissleder R, Harisinghani M.","Clin Imaging. 2009 Jul-Aug;33(4):301-5. doi: 10.1016/j.clinimag.2009.01.013.","Ross RW","Clin Imaging","2009","2009/06/30","","","10.1016/j.clinimag.2009.01.013"
"19251941","Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study","Mori K, Fukuda K, Asaoka H, Ueda T, Kunimatsu A, Okamoto Y, Nasu K, Fukunaga K, Morishita Y, Minami M.","Radiology. 2009 May;251(2):557-65. doi: 10.1148/radiol.2512081161. Epub 2009 Feb 27.","Mori K","Radiology","2009","2009/03/03","","","10.1148/radiol.2512081161"
"18791718","Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients","Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske AR, Gelderblom H, Awada A, Jusko WJ.","Cancer Chemother Pharmacol. 2009 May;63(6):1049-63. doi: 10.1007/s00280-008-0827-2. Epub 2008 Sep 13.","Bulitta JB","Cancer Chemother Pharmacol","2009","2008/09/16","","","10.1007/s00280-008-0827-2"
"19230915","Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy","Shepard DR, Dreicer R, Garcia J, Elson P, Magi-Galluzzi C, Raghavan D, Stephenson AJ, Klein EA.","J Urol. 2009 Apr;181(4):1672-7; discussion 1677. doi: 10.1016/j.juro.2008.11.121. Epub 2009 Feb 23.","Shepard DR","J Urol","2009","2009/02/24","","","10.1016/j.juro.2008.11.121"
"19224848","Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer","Teneriello MG, Tseng PC, Crozier M, Encarnacion C, Hancock K, Messing MJ, Boehm KA, Williams A, Asmar L.","J Clin Oncol. 2009 Mar 20;27(9):1426-31. doi: 10.1200/JCO.2008.18.9548. Epub 2009 Feb 17.","Teneriello MG","J Clin Oncol","2009","2009/02/20","","","10.1200/JCO.2008.18.9548"
"19087987","Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531)","Roy V, LaPlant BR, Gross GG, Bane CL, Palmieri FM; North Central Cancer Treatment Group.","Ann Oncol. 2009 Mar;20(3):449-53. doi: 10.1093/annonc/mdn661. Epub 2008 Dec 15.","Roy V","Ann Oncol","2009","2008/12/18","PMC2733073","","10.1093/annonc/mdn661"
"19228747","Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies","Tevaarwerk AJ, Holen KD, Alberti DB, Sidor C, Arnott J, Quon C, Wilding G, Liu G.","Clin Cancer Res. 2009 Feb 15;15(4):1460-5. doi: 10.1158/1078-0432.CCR-08-1599.","Tevaarwerk AJ","Clin Cancer Res","2009","2009/02/21","PMC2892631","NIHMS201010","10.1158/1078-0432.CCR-08-1599"
"18365196","Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study","Pires LA, Hegg R, Valduga CJ, Graziani SR, Rodrigues DG, Maranhão RC.","Cancer Chemother Pharmacol. 2009 Jan;63(2):281-7. doi: 10.1007/s00280-008-0738-2. Epub 2008 Mar 26.","Pires LA","Cancer Chemother Pharmacol","2009","2008/03/28","","","10.1007/s00280-008-0738-2"
"18926947","T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules","Chen RC, Lii JM, Chou CT, Chang TA, Chen WT, Li CS, Tu HY.","J Formos Med Assoc. 2008 Oct;107(10):798-805. doi: 10.1016/S0929-6646(08)60193-X.","Chen RC","J Formos Med Assoc","2008","2008/10/18","","","10.1016/S0929-6646(08)60193-X"
"18708295","MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study","Heesakkers RA, Hövels AM, Jager GJ, van den Bosch HC, Witjes JA, Raat HP, Severens JL, Adang EM, van der Kaa CH, Fütterer JJ, Barentsz J.","Lancet Oncol. 2008 Sep;9(9):850-6. doi: 10.1016/S1470-2045(08)70203-1. Epub 2008 Aug 15.","Heesakkers RA","Lancet Oncol","2008","2008/08/19","","","10.1016/S1470-2045(08)70203-1"
"18580337","Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation","Yoo HJ, Lee JM, Lee MW, Kim SJ, Lee JY, Han JK, Choi BI.","Invest Radiol. 2008 Jul;43(7):538-46. doi: 10.1097/RLI.0b013e3181768d96.","Yoo HJ","Invest Radiol","2008","2008/06/27","","","10.1097/RLI.0b013e3181768d96"
"18338834","Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial","Hüttinger C, Hirschberger J, Jahnke A, Köstlin R, Brill T, Plank C, Küchenhoff H, Krieger S, Schillinger U.","J Gene Med. 2008 Jun;10(6):655-67. doi: 10.1002/jgm.1185.","Hüttinger C","J Gene Med","2008","2008/03/15","","","10.1002/jgm.1185"
"18449006","Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies","Stinchcombe TE, Socinski MA, Lee CB, Hayes DN, Moore DT, Goldberg RM, Dees EC.","J Thorac Oncol. 2008 May;3(5):521-6. doi: 10.1097/JTO.0b013e31816de2a7.","Stinchcombe TE","J Thorac Oncol","2008","2008/05/02","PMC2860395","NIHMS192962","10.1097/JTO.0b013e31816de2a7"
"18423314","MR colonography with fecal tagging: barium vs. barium ferumoxsil","Achiam MP, Chabanova E, Løgager VB, Andersen LP, Thomsen HS, Rosenberg J.","Acad Radiol. 2008 May;15(5):576-83. doi: 10.1016/j.acra.2007.11.014.","Achiam MP","Acad Radiol","2008","2008/04/22","","","10.1016/j.acra.2007.11.014"
"18295316","Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer","Guimaraes AR, Tabatabei S, Dahl D, McDougal WS, Weissleder R, Harisinghani MG.","Urology. 2008 Apr;71(4):708-12. doi: 10.1016/j.urology.2007.11.096. Epub 2008 Mar 4.","Guimaraes AR","Urology","2008","2008/02/26","","","10.1016/j.urology.2007.11.096"
"18756943","[Injection of activated carbon nanoparticles for guiding lymphadenectomy during minimal invasive surgery in lung cancer]","Li SB, He JX, Chen HZ, Ge LH, Wei B, Yin WQ, Cheng XY, Liu J, Xu X.","Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):228-30.","Li SB","Zhonghua Zhong Liu Za Zhi","2008","2008/09/02","","",""
"18235124","Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer","Rizvi NA, Riely GJ, Azzoli CG, Miller VA, Ng KK, Fiore J, Chia G, Brower M, Heelan R, Hawkins MJ, Kris MG.","J Clin Oncol. 2008 Feb 1;26(4):639-43. doi: 10.1200/JCO.2007.10.8605.","Rizvi NA","J Clin Oncol","2008","2008/02/01","","","10.1200/JCO.2007.10.8605"
"18209043","Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans","Vogt A, Mahé B, Costagliola D, Bonduelle O, Hadam S, Schaefer G, Schaefer H, Katlama C, Sterry W, Autran B, Blume-Peytavi U, Combadiere B.","J Immunol. 2008 Feb 1;180(3):1482-9. doi: 10.4049/jimmunol.180.3.1482.","Vogt A","J Immunol","2008","2008/01/23","","","10.4049/jimmunol.180.3.1482"
"17912536","Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients","Annemans L, Lencioni R, Warie H, Bartolozzi C, Ciceri M, Müller U.","Int J Colorectal Dis. 2008 Jan;23(1):77-83. doi: 10.1007/s00384-007-0350-7. Epub 2007 Oct 2.","Annemans L","Int J Colorectal Dis","2008","2007/10/04","","","10.1007/s00384-007-0350-7"
"18269774","Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes","Blum JL, Savin MA, Edelman G, Pippen JE, Robert NJ, Geister BV, Kirby RL, Clawson A, O'Shaughnessy JA.","Clin Breast Cancer. 2007 Dec;7(11):850-6. doi: 10.3816/CBC.2007.n.049.","Blum JL","Clin Breast Cancer","2007","2008/02/14","","","10.3816/CBC.2007.n.049"
"18084623","Utility of a new bolus-injectable nanoparticle for clinical cancer staging","Harisinghani M, Ross RW, Guimaraes AR, Weissleder R.","Neoplasia. 2007 Dec;9(12):1160-5. doi: 10.1593/neo.07940.","Harisinghani M","Neoplasia","2007","2007/12/18","PMC2134912","","10.1593/neo.07940"
"18045346","Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study","Jahnke A, Hirschberger J, Fischer C, Brill T, Köstlin R, Plank C, Küchenhoff H, Krieger S, Kamenica K, Schillinger U.","J Vet Med A Physiol Pathol Clin Med. 2007 Dec;54(10):599-606. doi: 10.1111/j.1439-0442.2007.01002.x.","Jahnke A","J Vet Med A Physiol Pathol Clin Med","2007","2007/11/30","","","10.1111/j.1439-0442.2007.01002.x"
"17125906","Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution","Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N, Scholz R, Jordan A, Loening SA, Wust P.","Eur Urol. 2007 Dec;52(6):1653-61. doi: 10.1016/j.eururo.2006.11.023. Epub 2006 Nov 17.","Johannsen M","Eur Urol","2007","2006/11/28","","","10.1016/j.eururo.2006.11.023"
"18003990","Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx","Damascelli B, Patelli G, Tichá V, Di Tolla G, Frigerio LF, Garbagnati F, Lanocita R, Marchianò A, Spreafico C, Mattavelli F, Bruno A, Zunino F.","J Vasc Interv Radiol. 2007 Nov;18(11):1395-403. doi: 10.1016/j.jvir.2007.06.009.","Damascelli B","J Vasc Interv Radiol","2007","2007/11/16","","","10.1016/j.jvir.2007.06.009"
"17487349","Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes","Gordon EM, Chan MT, Geraldino N, Lopez FF, Cornelio GH, Lorenzo CC 3rd, Levy JP, Reed RA, Liu L, Hall FL.","Int J Oncol. 2007 Jun;30(6):1297-307.","Gordon EM","Int J Oncol","2007","2007/05/10","","",""
"17523023","Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial","Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldöfner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA.","Int J Hyperthermia. 2007 May;23(3):315-23. doi: 10.1080/02656730601175479.","Johannsen M","Int J Hyperthermia","2007","2007/05/25","","","10.1080/02656730601175479"
"16773216","Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme","Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, Jordan A.","J Neurooncol. 2007 Jan;81(1):53-60. doi: 10.1007/s11060-006-9195-0. Epub 2006 Jun 14.","Maier-Hauff K","J Neurooncol","2007","2006/06/15","","","10.1007/s11060-006-9195-0"
"17189412","HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan","Kitano S, Kageyama S, Nagata Y, Miyahara Y, Hiasa A, Naota H, Okumura S, Imai H, Shiraishi T, Masuya M, Nishikawa M, Sunamoto J, Akiyoshi K, Kanematsu T, Scott AM, Murphy R, Hoffman EW, Old LJ, Shiku H.","Clin Cancer Res. 2006 Dec 15;12(24):7397-405. doi: 10.1158/1078-0432.CCR-06-1546.","Kitano S","Clin Cancer Res","2006","2006/12/26","","","10.1158/1078-0432.CCR-06-1546"
"17114509","Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers","Saksena M, Harisinghani M, Hahn P, Kim J, Saokar A, King B, Weissleder R.","AJR Am J Roentgenol. 2006 Dec;187(6):W582-8. doi: 10.2214/AJR.05.0873.","Saksena M","AJR Am J Roentgenol","2006","2006/11/23","","","10.2214/AJR.05.0873"
"17101405","The role of SPIO-enhanced MRI in the detection of malignant liver lesions","Savranoglu P, Obuz F, Karasu S, Coker A, Secil M, Sagol O, Igci E, Dicle O, Astarcioglu I.","Clin Imaging. 2006 Nov-Dec;30(6):377-81. doi: 10.1016/j.clinimag.2006.06.001.","Savranoglu P","Clin Imaging","2006","2006/11/15","","","10.1016/j.clinimag.2006.06.001"
"16920315","Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging","Choi JY, Kim MJ, Kim JH, Kim SH, Ko HK, Lim JS, Oh YT, Chung JJ, Yoo HS, Lee JT, Kim KW.","Eur J Radiol. 2006 Oct;60(1):84-90. doi: 10.1016/j.ejrad.2006.06.016. Epub 2006 Aug 21.","Choi JY","Eur J Radiol","2006","2006/08/22","","","10.1016/j.ejrad.2006.06.016"
"16670863","Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings","Stadnik TW, Everaert H, Makkat S, Sacré R, Lamote J, Bourgain C.","Eur Radiol. 2006 Oct;16(10):2153-60. doi: 10.1007/s00330-006-0276-4. Epub 2006 May 3.","Stadnik TW","Eur Radiol","2006","2006/05/04","","","10.1007/s00330-006-0276-4"
"16755542","USPIO-enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer","Curvo-Semedo L, Diniz M, Miguéis J, Julião MJ, Martins P, Pinto A, Caseiro-Alves F.","J Magn Reson Imaging. 2006 Jul;24(1):123-31. doi: 10.1002/jmri.20602.","Curvo-Semedo L","J Magn Reson Imaging","2006","2006/06/07","","","10.1002/jmri.20602"
"16754352","18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma","Plotkin M, Gneveckow U, Meier-Hauff K, Amthauer H, Feussner A, Denecke T, Gutberlet M, Jordan A, Felix R, Wust P.","Int J Hyperthermia. 2006 Jun;22(4):319-25. doi: 10.1080/02656730600734128.","Plotkin M","Int J Hyperthermia","2006","2006/06/07","","","10.1080/02656730600734128"
"16641354","Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience","Heesakkers RA, Fütterer JJ, Hövels AM, van den Bosch HC, Scheenen TW, Hoogeveen YL, Barentsz JO.","Radiology. 2006 May;239(2):481-7. doi: 10.1148/radiol.2392050411.","Heesakkers RA","Radiology","2006","2006/04/28","","","10.1148/radiol.2392050411"
"16568431","Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions","Yoshikawa T, Mitchell DG, Hirota S, Ohno Y, Oda K, Maeda T, Fujii M, Sugimura K.","J Magn Reson Imaging. 2006 May;23(5):712-9. doi: 10.1002/jmri.20572.","Yoshikawa T","J Magn Reson Imaging","2006","2006/03/29","","","10.1002/jmri.20572"
"16554579","Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients","Kim HJ, Kim KW, Byun JH, Won HJ, Shin YM, Kim PN, Lee MS, Lee MG.","AJR Am J Roentgenol. 2006 Apr;186(4):1059-66. doi: 10.2214/AJR.04.1941.","Kim HJ","AJR Am J Roentgenol","2006","2006/03/24","","","10.2214/AJR.04.1941"
"16357394","Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?","Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT, Weissleder R.","AJR Am J Roentgenol. 2006 Jan;186(1):144-8. doi: 10.2214/AJR.04.1287.","Harisinghani MG","AJR Am J Roentgenol","2006","2005/12/17","","","10.2214/AJR.04.1287"
"16543699","Perfusion study of hypervascular hepatocellular carcinoma with SPIO","Saito K, Shindo H, Ozuki T, Ishikawa A, Kotake F, Shimazaki Y, Abe K.","Magn Reson Med Sci. 2005 Dec 31;4(4):151-8. doi: 10.2463/mrms.4.151.","Saito K","Magn Reson Med Sci","2005","2006/03/18","","","10.2463/mrms.4.151"
"16258082","Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies","Nyman DW, Campbell KJ, Hersh E, Long K, Richardson K, Trieu V, Desai N, Hawkins MJ, Von Hoff DD.","J Clin Oncol. 2005 Nov 1;23(31):7785-93. doi: 10.1200/JCO.2004.00.6148.","Nyman DW","J Clin Oncol","2005","2005/11/01","","","10.1200/JCO.2004.00.6148"
"16172456","Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O'Shaughnessy J.","J Clin Oncol. 2005 Nov 1;23(31):7794-803. doi: 10.1200/JCO.2005.04.937. Epub 2005 Sep 19.","Gradishar WJ","J Clin Oncol","2005","2005/09/21","","","10.1200/JCO.2005.04.937"
"16135470","Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer","Ibrahim NK, Samuels B, Page R, Doval D, Patel KM, Rao SC, Nair MK, Bhar P, Desai N, Hortobagyi GN.","J Clin Oncol. 2005 Sep 1;23(25):6019-26. doi: 10.1200/JCO.2005.11.013.","Ibrahim NK","J Clin Oncol","2005","2005/09/02","","","10.1200/JCO.2005.11.013"
"16080562","Systemic Lipoplatin infusion results in preferential tumor uptake in human studies","Boulikas T, Stathopoulos GP, Volakakis N, Vougiouka M.","Anticancer Res. 2005 Jul-Aug;25(4):3031-9.","Boulikas T","Anticancer Res","2005","2005/08/06","","",""
"15930349","Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol)","Sparreboom A, Scripture CD, Trieu V, Williams PJ, De T, Yang A, Beals B, Figg WD, Hawkins M, Desai N.","Clin Cancer Res. 2005 Jun 1;11(11):4136-43. doi: 10.1158/1078-0432.CCR-04-2291.","Sparreboom A","Clin Cancer Res","2005","2005/06/03","","","10.1158/1078-0432.CCR-04-2291"
"15837995","Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer","Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, Oram DH, Jacobs IJ, Shepherd JH, Reznek RH.","J Clin Oncol. 2005 Apr 20;23(12):2813-21. doi: 10.1200/JCO.2005.07.166.","Rockall AG","J Clin Oncol","2005","2005/04/20","","","10.1200/JCO.2005.07.166"
"15756428","Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study","Stathopoulos GP, Boulikas T, Vougiouka M, Deliconstantinos G, Rigatos S, Darli E, Viliotou V, Stathopoulos JG.","Oncol Rep. 2005 Apr;13(4):589-95.","Stathopoulos GP","Oncol Rep","2005","2005/03/10","","",""
"15810637","Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography","Lencioni R, Della Pina C, Bruix J, Majno P, Grazioli L, Morana G, Filippone A, Laghi A, Bartolozzi C.","Dig Dis Sci. 2005 Mar;50(3):533-7. doi: 10.1007/s10620-005-2469-0.","Lencioni R","Dig Dis Sci","2005","2005/04/07","","","10.1007/s10620-005-2469-0"
"15566651","[A tolerability study of A cremophor-free albumin bound nanoparticle paclitaxel intravenously administered in patients with advanced solid tumor]","Teng XY, Guan ZZ, Yao ZW, Liu DG, Zhou NN, Luo HY, Hawkins M, Soon-Shiong P.","Ai Zheng. 2004 Nov;23(11 Suppl):1431-6.","Teng XY","Ai Zheng","2004","2004/11/30","","",""
"15503325","Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging","Kim YK, Kim CS, Kwak HS, Lee JM.","J Magn Reson Imaging. 2004 Nov;20(5):826-37. doi: 10.1002/jmri.20188.","Kim YK","J Magn Reson Imaging","2004","2004/10/27","","","10.1002/jmri.20188"
"15486527","Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms","Laghi A, Paolantonio P, Panebianco V, Miglio C, Iafrate F, Di Tondo U, Passariello R.","Invest Radiol. 2004 Nov;39(11):666-70. doi: 10.1097/00004424-200411000-00004.","Laghi A","Invest Radiol","2004","2004/10/16","","","10.1097/00004424-200411000-00004"
"15113062","Preoperative patient work-up: Resovist-enhanced MRI vs. multislice CT--preliminary results of an ongoing study","Heinz-Peer G.","Eur Radiol. 2004 Jan;14 Suppl 1:C11-2.","Heinz-Peer G","Eur Radiol","2004","2004/04/29","","",""
"15113061","Clinical impact of Resovist-enhanced MRI: results of an Italian multicenter trial","Lencioni R, Bartolozzi C; Italian Study Group.","Eur Radiol. 2004 Jan;14 Suppl 1:C10.","Lencioni R","Eur Radiol","2004","2004/04/29","","",""
"15113060","Experience with Resovist in gastroenterologic radiology and intervention","Vogl TJ, Schwarz W, Marquart F, Parmentier S, Götz B, Thalhammer A, Hammerstingl R.","Eur Radiol. 2004 Jan;14 Suppl 1:C7-9.","Vogl TJ","Eur Radiol","2004","2004/04/29","","",""
"14732978","[Clinical application of anticancer nanoparticles targeting metastasis foci of cervical lymph nodes in patients with oral carcinoma]","Yang K, Wen Y, Wang C.","Hua Xi Kou Qiang Yi Xue Za Zhi. 2003 Dec;21(6):447-50.","Yang K","Hua Xi Kou Qiang Yi Xue Za Zhi","2003","2004/01/22","","",""
"14576446","Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial","Daldrup-Link HE, Rydland J, Helbich TH, Bjørnerud A, Turetschek K, Kvistad KA, Kaindl E, Link TM, Staudacher K, Shames D, Brasch RC, Haraldseth O, Rummeny EJ.","Radiology. 2003 Dec;229(3):885-92. doi: 10.1148/radiol.2293021045. Epub 2003 Oct 23.","Daldrup-Link HE","Radiology","2003","2003/10/25","","","10.1148/radiol.2293021045"
"14699862","[Dose investigation of superparamagnetic iron oxide (SPIO) SH U 555 A in liver MR imaging]","Hirohashi S, Ichikawa T, Tanimoto A, Isobe Y, Hachiya J, Saito K, Isoda H, Nishimura H, Kuwatsuru R, Gokan T, Murakami T, Nakano S, Seriu T.","Nihon Igaku Hoshasen Gakkai Zasshi. 2003 Nov;63(9):539-50.","Hirohashi S","Nihon Igaku Hoshasen Gakkai Zasshi","2003","2004/01/01","","",""
"12954896","Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study","Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM; Group.","Radiology. 2003 Sep;228(3):777-88. doi: 10.1148/radiol.2283020872.","Anzai Y","Radiology","2003","2003/09/05","","","10.1148/radiol.2283020872"
"12893904","Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol","Bluemke DA, Weber TM, Rubin D, de Lange EE, Semelka R, Redvanly RD, Chezmar J, Outwater E, Carlos R, Saini S, Holland GA, Mammone JF, Brown JJ, Milestone B, Javitt MC, Jacobs P.","Radiology. 2003 Aug;228(2):457-64. doi: 10.1148/radiol.2282012061.","Bluemke DA","Radiology","2003","2003/08/02","","","10.1148/radiol.2282012061"
"12751998","New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer","Rydland J, BjØrnerud A, Haugen O, Torheim G, Torres C, Kvistad KA, Haraldseth O.","Acta Radiol. 2003 May;44(3):275-83. doi: 10.1034/j.1600-0455.2003.00068.x.","Rydland J","Acta Radiol","2003","2003/05/20","","","10.1034/j.1600-0455.2003.00068.x"
"12598989","Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US","Vogl TJ, Schwarz W, Blume S, Pietsch M, Shamsi K, Franz M, Lobeck H, Balzer T, del Tredici K, Neuhaus P, Felix R, Hammerstingl RM.","Eur Radiol. 2003 Feb;13(2):262-72. doi: 10.1007/s00330-002-1677-7. Epub 2002 Sep 10.","Vogl TJ","Eur Radiol","2003","2003/02/25","","","10.1007/s00330-002-1677-7"
"12952499","ABI 007","","Drugs R D. 2003;4(5):303-5. doi: 10.2165/00126839-200304050-00004.","","Drugs R D","2003","2003/09/04","","","10.2165/00126839-200304050-00004"
"12409591","Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement","Michel SC, Keller TM, Fröhlich JM, Fink D, Caduff R, Seifert B, Marincek B, Kubik-Huch RA.","Radiology. 2002 Nov;225(2):527-36. doi: 10.1148/radiol.2252011605.","Michel SC","Radiology","2002","2002/11/01","","","10.1148/radiol.2252011605"
"12185056","Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging","Kim SK, Kim SH, Lee WJ, Kim H, Seo JW, Choi D, Lim HK, Lee SJ, Lim JH.","AJR Am J Roentgenol. 2002 Sep;179(3):741-50. doi: 10.2214/ajr.179.3.1790741.","Kim SK","AJR Am J Roentgenol","2002","2002/08/20","","","10.2214/ajr.179.3.1790741"
"12188326","MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model","Turetschek K, Preda A, Floyd E, Shames DM, Novikov V, Roberts TP, Wood JM, Fu Y, Carter WO, Brasch RC.","Acad Radiol. 2002 Aug;9 Suppl 2:S519-20. doi: 10.1016/s1076-6332(03)80281-7.","Turetschek K","Acad Radiol","2002","2002/08/22","","","10.1016/s1076-6332(03)80281-7"
"12006516","Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel","Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA.","Clin Cancer Res. 2002 May;8(5):1038-44.","Ibrahim NK","Clin Cancer Res","2002","2002/05/15","","",""
"11976854","Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial","Sigal R, Vogl T, Casselman J, Moulin G, Veillon F, Hermans R, Dubrulle F, Viala J, Bosq J, Mack M, Depondt M, Mattelaer C, Petit P, Champsaur P, Riehm S, Dadashitazehozi Y, de Jaegere T, Marchal G, Chevalier D, Lemaitre L, Kubiak C, Helmberger R, Halimi P.","Eur Radiol. 2002 May;12(5):1104-13. doi: 10.1007/s003300101130. Epub 2001 Oct 18.","Sigal R","Eur Radiol","2002","2002/04/27","","","10.1007/s003300101130"
"11833077","Characterization of focal hepatic lesions with SPIO-enhanced MRI","Zheng WW, Zhou KR, Chen ZW, Shen JZ, Chen CZ, Zhang SJ.","World J Gastroenterol. 2002 Feb;8(1):82-6. doi: 10.3748/wjg.v8.i1.82.","Zheng WW","World J Gastroenterol","2002","2002/02/08","PMC4656632","","10.3748/wjg.v8.i1.82"
"11756732","Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes","Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ.","Radiology. 2002 Jan;222(1):239-44. doi: 10.1148/radiol.2221010225.","Mack MG","Radiology","2002","2002/01/05","","","10.1148/radiol.2221010225"
"11745194","Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): Phase I study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity","Damascelli B, Cantù G, Mattavelli F, Tamplenizza P, Bidoli P, Leo E, Dosio F, Cerrotta AM, Di Tolla G, Frigerio LF, Garbagnati F, Lanocita R, Marchianò A, Patelli G, Spreafico C, Tichà V, Vespro V, Zunino F.","Cancer. 2001 Nov 15;92(10):2592-602. doi: 10.1002/1097-0142(20011115)92:10<2592::aid-cncr1612>3.0.co;2-4.","Damascelli B","Cancer","2001","2001/12/18","","","10.1002/1097-0142(20011115)92:10<2592::aid-cncr1612>3.0.co;2-4"
"11747012","Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A)","Kehagias DT, Gouliamos AD, Smyrniotis V, Vlahos LJ.","J Magn Reson Imaging. 2001 Nov;14(5):595-601. doi: 10.1002/jmri.1224.","Kehagias DT","J Magn Reson Imaging","2001","2001/12/18","","","10.1002/jmri.1224"
"11418408","MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension","Braga HJ, Imam K, Bluemke DA.","AJR Am J Roentgenol. 2001 Jul;177(1):111-4. doi: 10.2214/ajr.177.1.1770111.","Braga HJ","AJR Am J Roentgenol","2001","2001/06/22","","","10.2214/ajr.177.1.1770111"
"11012438","Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis","Reimer P, Jähnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N, Saini S.","Radiology. 2000 Oct;217(1):152-8. doi: 10.1148/radiology.217.1.r00oc31152.","Reimer P","Radiology","2000","2000/09/30","","","10.1148/radiology.217.1.r00oc31152"
"10988047","Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging","Saini S, Sharma R, Baron RL, Turner DA, Ros PR, Hahn PF, Small WC, Delange EE, Stillman AE, Edelman RR, Runge VM, Outwater EK.","Clin Radiol. 2000 Sep;55(9):690-5. doi: 10.1053/crad.2000.0504.","Saini S","Clin Radiol","2000","2000/09/16","","","10.1053/crad.2000.0504"
"10862066","Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP","Ba-Ssalamah A, Heinz-Peer G, Schima W, Schibany N, Schick S, Prokesch RW, Kaider A, Teleky B, Wrba F, Lechner G.","J Magn Reson Imaging. 2000 Jun;11(6):665-72. doi: 10.1002/1522-2586(200006)11:6<665::aid-jmri13>3.0.co;2-d.","Ba-Ssalamah A","J Magn Reson Imaging","2000","2000/06/22","","","10.1002/1522-2586(200006)11:6<665::aid-jmri13>3.0.co;2-d"
"10862064","Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging","Nakayama M, Yamashita Y, Mitsuzaki K, Yi T, Arakawa A, Katahira K, Nakayama Y, Takahashi M.","J Magn Reson Imaging. 2000 Jun;11(6):647-54. doi: 10.1002/1522-2586(200006)11:6<647::aid-jmri11>3.0.co;2-f.","Nakayama M","J Magn Reson Imaging","2000","2000/06/22","","","10.1002/1522-2586(200006)11:6<647::aid-jmri11>3.0.co;2-f"
"10745140","Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence","Said B, McCart JA, Libutti SK, Choyke PL.","Magn Reson Imaging. 2000 Apr;18(3):305-9. doi: 10.1016/s0730-725x(99)00134-4.","Said B","Magn Reson Imaging","2000","2000/04/04","","","10.1016/s0730-725x(99)00134-4"
"10745139","MRI of liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases","Scott J, Ward J, Guthrie JA, Wilson D, Robinson PJ.","Magn Reson Imaging. 2000 Apr;18(3):297-303. doi: 10.1016/s0730-725x(00)00116-8.","Scott J","Magn Reson Imaging","2000","2000/04/04","","","10.1016/s0730-725x(00)00116-8"
"10675457","Detection of hepatocellular carcinoma and its metastases with various pulse sequences using superparamagnetic iron oxide (SHU-555-A)","Arbab AS, Ichikawa T, Araki T, Toyama K, Nambu A, Ohsawa S, Kumagai H, Aikawa Y.","Abdom Imaging. 2000 Mar-Apr;25(2):151-8. doi: 10.1007/s002619910035.","Arbab AS","Abdom Imaging","2000","2000/02/17","","","10.1007/s002619910035"
"10508310","Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma","Nguyen BC, Stanford W, Thompson BH, Rossi NP, Kernstine KH, Kern JA, Robinson RA, Amorosa JK, Mammone JF, Outwater EK.","J Magn Reson Imaging. 1999 Sep;10(3):468-73. doi: 10.1002/(sici)1522-2586(199909)10:3<468::aid-jmri31>3.0.co;2-i.","Nguyen BC","J Magn Reson Imaging","1999","1999/10/03","","","10.1002/(sici)1522-2586(199909)10:3<468::aid-jmri31>3.0.co;2-i"
"10397122","Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging","Grubnic S, Padhani AR, Revell PB, Husband JE.","AJR Am J Roentgenol. 1999 Jul;173(1):173-8. doi: 10.2214/ajr.173.1.10397122.","Grubnic S","AJR Am J Roentgenol","1999","1999/07/09","","","10.2214/ajr.173.1.10397122"
"10227514","MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation","Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR.","AJR Am J Roentgenol. 1999 May;172(5):1347-51. doi: 10.2214/ajr.172.5.10227514.","Harisinghani MG","AJR Am J Roentgenol","1999","1999/05/05","","","10.2214/ajr.172.5.10227514"
"10077018","Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent","Enochs WS, Harsh G, Hochberg F, Weissleder R.","J Magn Reson Imaging. 1999 Feb;9(2):228-32. doi: 10.1002/(sici)1522-2586(199902)9:2<228::aid-jmri12>3.0.co;2-k.","Enochs WS","J Magn Reson Imaging","1999","1999/03/17","","","10.1002/(sici)1522-2586(199902)9:2<228::aid-jmri12>3.0.co;2-k"
"9786144","MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents","Mergo PJ, Engelken JD, Helmberger T, Ros PR.","J Magn Reson Imaging. 1998 Sep-Oct;8(5):1073-8. doi: 10.1002/jmri.1880080511.","Mergo PJ","J Magn Reson Imaging","1998","1998/10/24","","","10.1002/jmri.1880080511"
"9609907","Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience","Bellin MF, Roy C, Kinkel K, Thoumas D, Zaim S, Vanel D, Tuchmann C, Richard F, Jacqmin D, Delcourt A, Challier E, Lebret T, Cluzel P.","Radiology. 1998 Jun;207(3):799-808. doi: 10.1148/radiology.207.3.9609907.","Bellin MF","Radiology","1998","1998/06/04","","","10.1148/radiology.207.3.9609907"
"9626884","Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI","Semelka RC, Lee JK, Worawattanakul S, Noone TC, Patt RH, Ascher SM.","J Magn Reson Imaging. 1998 May-Jun;8(3):670-4. doi: 10.1002/jmri.1880080323.","Semelka RC","J Magn Reson Imaging","1998","1998/06/17","","","10.1002/jmri.1880080323"
"9561072","MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex)","Harisinghani MG, Saini S, Hahn PF, Weissleder R, Mueller PR.","Acad Radiol. 1998 Apr;5 Suppl 1:S167-9, discussion S183-4. doi: 10.1016/s1076-6332(98)80095-0.","Harisinghani MG","Acad Radiol","1998","1998/04/30","","","10.1016/s1076-6332(98)80095-0"
"9561049","Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient","Hammerstingl R, Vogl TJ, Schwarz W, Kümmel S, Balzer T, Neuhaus P, Felix R.","Acad Radiol. 1998 Apr;5 Suppl 1:S75-9; discussion S93-4. doi: 10.1016/s1076-6332(98)80066-4.","Hammerstingl R","Acad Radiol","1998","1998/04/30","","","10.1016/s1076-6332(98)80066-4"
"9493719","Detection of focal hepatic lesions: effects of superparamagnetic iron oxide (AMI-25) on magnetic resonance imaging of the liver using T2-weighted fast spin-echo sequences and gradient-and-spin-echo sequences at 1.0 tesla","Jung G, Krahe T, Kugel H, Gieseke J, Walter C, Lackner K.","Invest Radiol. 1998 Feb;33(2):61-7. doi: 10.1097/00004424-199802000-00001.","Jung G","Invest Radiol","1998","1998/03/11","","","10.1097/00004424-199802000-00001"
"9457187","Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging","Shamsi K, Balzer T, Saini S, Ros PR, Nelson RC, Carter EC, Tollerfield S, Niendorf HP.","Radiology. 1998 Feb;206(2):365-71. doi: 10.1148/radiology.206.2.9457187.","Shamsi K","Radiology","1998","1998/02/11","","","10.1148/radiology.206.2.9457187"
"9400845","MRI of pelvic masses: efficacy of the rectal superparamagnetic contrast agent Ferumoxsil","Scheidler J, Heuck AF, Meier W, Reiser MF.","J Magn Reson Imaging. 1997 Nov-Dec;7(6):1027-32. doi: 10.1002/jmri.1880070614.","Scheidler J","J Magn Reson Imaging","1997","1997/12/24","","","10.1002/jmri.1880070614"
"9394654","Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging","Strotzer M, Gmeinwieser J, Schmidt J, Fellner C, Seitz J, Albrich H, Zirngibl H, Feuerbach S.","Acta Radiol. 1997 Nov;38(6):986-92. doi: 10.1080/02841859709172115.","Strotzer M","Acta Radiol","1997","1997/12/12","","","10.1080/02841859709172115"
"9376555","[Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors]","Vogl TJ, Schwarz W, Hammerstingl R, Kümmel S, Balzer JO, Mack MG, Diebold T, Balzer T, Shamsi K, Bechstein WO, Schrem H, Neuhaus P, Felix R.","Rofo. 1997 Sep;167(3):264-73. doi: 10.1055/s-2007-1015530.","Vogl TJ","Rofo","1997","1998/02/12","","","10.1055/s-2007-1015530"
"9280254","MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties","Kopp AF, Laniado M, Dammann F, Stern W, Grönewäller E, Balzer T, Schimpfky C, Claussen CD.","Radiology. 1997 Sep;204(3):749-56. doi: 10.1148/radiology.204.3.9280254.","Kopp AF","Radiology","1997","1997/09/01","","","10.1148/radiology.204.3.9280254"
"9157855","The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles","Laniado M, Grönewäller E, Kopp AF, Kaminsky SF, Hamm B, Jacobsen TF, Claussen CD.","Abdom Imaging. 1997 Jul-Aug;22(4):381-8. doi: 10.1007/s002619900215.","Laniado M","Abdom Imaging","1997","1997/07/01","","","10.1007/s002619900215"
"9170031","Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization","van Gansbeke D, Metens TM, Matos C, Nicaise N, Gay F, Raeymaekers H, Struyven J.","J Magn Reson Imaging. 1997 May-Jun;7(3):482-9. doi: 10.1002/jmri.1880070306.","van Gansbeke D","J Magn Reson Imaging","1997","1997/05/01","","","10.1002/jmri.1880070306"
"9051017","Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227","Harisinghani MG, Saini S, Weissleder R, Halpern EF, Schima W, Rubin DL, Stillman AE, Sica GT, Small WC, Hahn PF.","Radiology. 1997 Mar;202(3):687-91. doi: 10.1148/radiology.202.3.9051017.","Harisinghani MG","Radiology","1997","1997/03/01","","","10.1148/radiology.202.3.9051017"
"9228104","The influence of MR field strength on the detection of focal liver lesions with superparamagnetic iron oxide","Deckers F, Corthouts B, Nackaerts Y, Ozsarlak O, Parizel PM, De Schepper AM.","Eur Radiol. 1997;7(6):887-92. doi: 10.1007/s003300050222.","Deckers F","Eur Radiol","1997","1997/01/01","","","10.1007/s003300050222"
"8915751","Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient","Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R.","Invest Radiol. 1996 Nov;31(11):696-708. doi: 10.1097/00004424-199611000-00004.","Vogl TJ","Invest Radiol","1996","1996/11/01","","","10.1097/00004424-199611000-00004"
"8796619","Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver","Balzer T, Carter EC, Shamsi K, Niendorf HP.","Acad Radiol. 1996 Aug;3 Suppl 2:S417-9. doi: 10.1016/s1076-6332(96)80603-9.","Balzer T","Acad Radiol","1996","1996/08/01","","","10.1016/s1076-6332(96)80603-9"
"8796616","Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging","Saini S, Edelman RR, Li W, Petersein J, Hahn PF.","Acad Radiol. 1996 Aug;3 Suppl 2:S409-12. doi: 10.1016/s1076-6332(96)80600-3.","Saini S","Acad Radiol","1996","1996/08/01","","","10.1016/s1076-6332(96)80600-3"
"8647782","Diagnostic improvement in MRI of gynecological neoplasms","Marincek B.","J Belge Radiol. 1996 Feb;79(1):13-7.","Marincek B","J Belge Radiol","1996","1996/02/01","","",""
"8553952","Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions","Mergo PJ, Helmberger T, Nicolas AI, Ros PR.","AJR Am J Roentgenol. 1996 Feb;166(2):379-84. doi: 10.2214/ajr.166.2.8553952.","Mergo PJ","AJR Am J Roentgenol","1996","1996/02/01","","","10.2214/ajr.166.2.8553952"
"8588032","[Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem]","Vogl TJ, Hammerstingl R, Keck H, Felix R.","Radiologe. 1995 Nov;35(11 Suppl 2):S258-66.","Vogl TJ","Radiologe","1995","1995/11/01","","",""
"7617864","Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions","Ros PR, Freeny PC, Harms SE, Seltzer SE, Davis PL, Chan TW, Stillman AE, Muroff LR, Runge VM, Nissenbaum MA, et al.","Radiology. 1995 Aug;196(2):481-8. doi: 10.1148/radiology.196.2.7617864.","Ros PR","Radiology","1995","1995/08/01","","","10.1148/radiology.196.2.7617864"
"7617863","Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US","Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B.","Radiology. 1995 Aug;196(2):471-8. doi: 10.1148/radiology.196.2.7617863.","Hagspiel KD","Radiology","1995","1995/08/01","","","10.1148/radiology.196.2.7617863"
"7568792","[New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors]","Daldrup HE, Reimer P, Rummeny EJ, Tombach B, Berns T, Balzer T, Schimpfky C, Peters PE.","Radiologe. 1995 Aug;35(8):486-93.","Daldrup HE","Radiologe","1995","1995/08/01","","",""
"7549199","Oral superparamagnetic contrast agent (ferumoxsil): tolerance and efficacy in MR imaging of gynecologic diseases","Haldemann Heusler RC, Wight E, Marincek B.","J Magn Reson Imaging. 1995 Jul-Aug;5(4):385-91. doi: 10.1002/jmri.1880050404.","Haldemann Heusler RC","J Magn Reson Imaging","1995","1995/07/01","","","10.1002/jmri.1880050404"
"7724772","Clinical results with Resovist: a phase 2 clinical trial","Reimer P, Rummeny EJ, Daldrup HE, Balzer T, Tombach B, Berns T, Peters PE.","Radiology. 1995 May;195(2):489-96. doi: 10.1148/radiology.195.2.7724772.","Reimer P","Radiology","1995","1995/05/01","","","10.1148/radiology.195.2.7724772"
"7892448","Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging","Yamamoto H, Yamashita Y, Yoshimatsu S, Baba Y, Hatanaka Y, Murakami R, Nishiharu T, Takahashi M, Higashida Y, Moribe N.","Radiology. 1995 Apr;195(1):106-12. doi: 10.1148/radiology.195.1.7892448.","Yamamoto H","Radiology","1995","1995/04/01","","","10.1148/radiology.195.1.7892448"
"7972805","Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25","Denys A, Arrive L, Servois V, Dubray B, Najmark D, Sibert A, Menu Y.","Radiology. 1994 Dec;193(3):665-9. doi: 10.1148/radiology.193.3.7972805.","Denys A","Radiology","1994","1994/12/01","","","10.1148/radiology.193.3.7972805"
"7972804","Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging","Bellin MF, Zaim S, Auberton E, Sarfati G, Duron JJ, Khayat D, Grellet J.","Radiology. 1994 Dec;193(3):657-63. doi: 10.1148/radiology.193.3.7972804.","Bellin MF","Radiology","1994","1994/12/01","","","10.1148/radiology.193.3.7972804"
"7962795","Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles","Grangier C, Tourniaire J, Mentha G, Schiau R, Howarth N, Chachuat A, Grossholz M, Terrier F.","J Comput Assist Tomogr. 1994 Nov-Dec;18(6):888-96. doi: 10.1097/00004728-199411000-00008.","Grangier C","J Comput Assist Tomogr","1994","1994/11/01","","","10.1097/00004728-199411000-00008"
"8061426","Superparamagnetic iron oxide: detection of focal liver lesions at high-field-strength MR imaging","Duda SH, Laniado M, Kopp AF, Grönewäller E, Aicher KP, Pavone P, Jehle E, Claussen CD.","J Magn Reson Imaging. 1994 May-Jun;4(3):309-14. doi: 10.1002/jmri.1880040314.","Duda SH","J Magn Reson Imaging","1994","1994/05/01","","","10.1002/jmri.1880040314"
"8161744","[The value of the liver-specific superparamagnetic contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors versus metastases]","Vogl TJ, Hammerstingl R, Pegios W, Hamm B, Eibl-Eibesfeldt A, Woessmer B, Lissner J, Felix R.","Rofo. 1994 Apr;160(4):319-28. doi: 10.1055/s-2008-1032431.","Vogl TJ","Rofo","1994","1994/04/01","","","10.1055/s-2008-1032431"
"8121779","[Clinical application of AMI-25 (superparamagnetic iron oxide) for the MR imaging of hepatic tumors: a multicenter clinical phase III study]","Yoshikawa K, Sasaki Y, Ogawa N, Sakuma S.","Nihon Igaku Hoshasen Gakkai Zasshi. 1994 Feb 25;54(2):137-53.","Yoshikawa K","Nihon Igaku Hoshasen Gakkai Zasshi","1994","1994/02/25","","",""
"8305693","[Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases]","Ham B, Reichel M, Vogl T, Taupitz M, Wolf KJ.","Rofo. 1994 Jan;160(1):52-8.","Ham B","Rofo","1994","1994/01/01","","",""
"8305692","[The MR tomography of focal liver lesions with the superparamagnetic contrast agent AMI-25 at 1.5 tesla]","Duda SH, Laniado M, Kopp AF, Grönewäller E, Aicher KP, Pavone P, Jehle E, Claussen CD.","Rofo. 1994 Jan;160(1):46-51. doi: 10.1055/s-2008-1032371.","Duda SH","Rofo","1994","1994/01/01","","","10.1055/s-2008-1032371"
"8319063","Abdominal MRI using a negative contrast agent","Bach-Gansmo T, Dupas B, Gayet-Delacroix M, Lambrechts M.","Br J Radiol. 1993 May;66(785):420-5. doi: 10.1259/0007-1285-66-785-420.","Bach-Gansmo T","Br J Radiol","1993","1993/05/01","","","10.1259/0007-1285-66-785-420"
"8472481","Phase III trial of oral magnetic particles in MRI of abdomen and pelvis","MacVicar D, Jacobsen TF, Guy R, Husband JE.","Clin Radiol. 1993 Mar;47(3):183-8. doi: 10.1016/s0009-9260(05)81159-6.","MacVicar D","Clin Radiol","1993","1993/03/01","","","10.1016/s0009-9260(05)81159-6"
"1428729","Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles","Kattan J, Droz JP, Couvreur P, Marino JP, Boutan-Laroze A, Rougier P, Brault P, Vranckx H, Grognet JM, Morge X, et al.","Invest New Drugs. 1992 Aug;10(3):191-9. doi: 10.1007/BF00877245.","Kattan J","Invest New Drugs","1992","1992/08/01","","","10.1007/BF00877245"
"1994417","Oral magnetic particles in MR imaging of the abdomen and pelvis","Rinck PA, Smevik O, Nilsen G, Klepp O, Onsrud M, Oksendal A, Børseth A.","Radiology. 1991 Mar;178(3):775-9. doi: 10.1148/radiology.178.3.1994417.","Rinck PA","Radiology","1991","1991/03/01","","","10.1148/radiology.178.3.1994417"
